| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | molecular adaptor activity | DAB2IP ZXDC TRPC4AP GATAD2A RRP1B DISC1 IRAK2 SUPT20HL2 BCL9 ECSIT BCOR KLF4 YTHDF1 WWC2 TSC22D1 MRTFB YAP1 G3BP2 TRIM8 MICAL3 ZNF541 CAPN3 SHC1 EID2B DVL3 POU2AF1 NLRP1 MED13L TAB3 YEATS2 NCOR1 TLE3 EIF4G1 NCOA1 SMARCC2 MYOCD RERE KAT6B MUC1 EP300 HR | 2.57e-09 | 1356 | 219 | 41 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coregulator activity | ZXDC RRP1B SUPT20HL2 BCL9 BCOR TSC22D1 MRTFB YAP1 TRIM8 ZNF541 EID2B POU2AF1 MED13L YEATS2 NCOR1 TLE3 NCOA1 SMARCC2 MYOCD RERE KAT6B MUC1 EP300 HR | 1.46e-08 | 562 | 219 | 24 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DAB2IP ZXDC TRPC4AP GATAD2A RRP1B IRAK2 SUPT20HL2 BCL9 BCOR KLF4 YTHDF1 WWC2 TSC22D1 MRTFB YAP1 G3BP2 TRIM8 ZNF541 SHC1 EID2B DVL3 POU2AF1 NLRP1 MED13L YEATS2 NCOR1 TLE3 NCOA1 SMARCC2 MYOCD RERE KAT6B MUC1 EP300 HR | 4.78e-08 | 1160 | 219 | 35 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coactivator activity | ZXDC RRP1B BCL9 TSC22D1 MRTFB YAP1 TRIM8 POU2AF1 NCOA1 SMARCC2 MYOCD RERE KAT6B EP300 | 6.88e-06 | 303 | 219 | 14 | GO:0003713 |
| GeneOntologyMolecularFunction | protein antigen binding | 2.31e-05 | 16 | 219 | 4 | GO:1990405 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 3.62e-04 | 120 | 219 | 7 | GO:0008013 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | DAB2IP ZNF536 GATAD2A BCOR KLF4 TENM2 CIC BAP1 WWC2 YAP1 GLI2 PLCB1 SAP130 ZNF541 ZNF703 TCF7 NOP53 CAPN3 SHC1 EID2B YBX3 YEATS2 NCOR1 TLE3 YLPM1 OSR1 SMARCC2 SIX5 MYOCD RERE GREM1 KAT6B MUC1 EP300 HR | 2.31e-06 | 1399 | 221 | 35 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | DAB2IP ZNF536 GATAD2A BCOR KLF4 TENM2 CIC BAP1 WWC2 YAP1 GLI2 PLCB1 SAP130 ZNF541 ZNF703 TCF7 NOP53 CAPN3 SHC1 EID2B YBX3 YEATS2 NCOR1 TLE3 YLPM1 OSR1 SMARCC2 SIX5 MYOCD RERE GREM1 KAT6B MUC1 EP300 HR | 2.88e-06 | 1413 | 221 | 35 | GO:1902679 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 1.63e-05 | 136 | 221 | 9 | GO:0045445 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | DAB2IP AMER1 DISC1 BCL9 KLF4 YAP1 ZNF703 TCF7 DVL3 AMER3 LRRK1 CSNK1G2 TLE3 GREM1 | 2.21e-05 | 344 | 221 | 14 | GO:0060070 |
| GeneOntologyBiologicalProcess | regulation of protein modification process | DAB2IP AMER1 MYCBP2 SIRPB1 SIRPA PTBP1 CMYA5 PLXNB2 NOD2 GHR LIME1 ADRA1A HPX BCAR3 MVP NOS1 SERTAD1 NOP53 CAPN3 DVL3 LRRK1 HUWE1 YEATS2 THPO VCAN EIF4G1 MYOCD PRKD1 DUSP10 GREM1 MARK2 MAPK8 EP300 INPP5J | 2.24e-05 | 1488 | 221 | 34 | GO:0031399 |
| GeneOntologyBiologicalProcess | response to interleukin-1 | 2.80e-05 | 112 | 221 | 8 | GO:0070555 | |
| GeneOntologyBiologicalProcess | regulation of growth | DAB2IP MYCBP2 KIF26A DISC1 AZGP1 BAP1 GHR WWC2 SPAAR YAP1 PLCB1 SERTAD1 CAPN3 YBX3 NCOR1 CSF2RB EIF4G1 MYOCD DUSP10 RIMS1 GREM1 EP300 | 3.40e-05 | 777 | 221 | 22 | GO:0040008 |
| GeneOntologyBiologicalProcess | cellular response to interleukin-1 | 3.58e-05 | 85 | 221 | 7 | GO:0071347 | |
| GeneOntologyBiologicalProcess | growth | DAB2IP XIRP1 MYCBP2 KIF26A DISC1 AZGP1 BCL9 BAP1 GHR WWC2 ADRA1A SPAAR YAP1 FMN1 GLI2 PLCB1 SERTAD1 CAPN3 YBX3 NCOR1 CSF2RB EIF4G1 ANKRD11 MYOCD DUSP10 RIMS1 GREM1 EP300 VPS13B | 5.92e-05 | 1235 | 221 | 29 | GO:0040007 |
| GeneOntologyBiologicalProcess | canonical NF-kappaB signal transduction | DAB2IP IRAK2 SIRPB1 SIRPA NOD2 LIME1 NFKB2 TRIM8 CARD6 CAPN3 TAB3 PRKD1 EP300 | 6.08e-05 | 330 | 221 | 13 | GO:0007249 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | GATAD2A MBNL1 BCOR MFRP KLF4 PLXNB2 BIRC6 BAP1 MRTFB YAP1 AMOT GLI2 PRRC2B TCF7 ZFAT CAMSAP3 DVL3 YBX3 NCOR1 OSR1 ANKRD11 NCOA1 PCDH8 EP300 | 6.34e-05 | 929 | 221 | 24 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | DAB2IP RRP1B PLXND1 PLXNB2 AMOT BCAR3 RAP1GAP DVL3 FICD ARHGEF10 SIPA1L1 TBCK USP6NL | 7.08e-05 | 335 | 221 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | STAM2 WDR81 NOD2 SPATA33 ADRA1A TRIM8 BAG3 LARP1 VTA1 HUWE1 ZNRF2 TAB3 WDR6 EIF4G1 LAMP3 PRKD1 MARK2 MAPK8 EP300 | 7.84e-05 | 650 | 221 | 19 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | STAM2 WDR81 NOD2 SPATA33 ADRA1A TRIM8 BAG3 LARP1 VTA1 HUWE1 ZNRF2 TAB3 WDR6 EIF4G1 LAMP3 PRKD1 MARK2 MAPK8 EP300 | 7.84e-05 | 650 | 221 | 19 | GO:0006914 |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | DAB2IP AMER1 MYCBP2 DISC1 DAZL PTBP1 KLF4 PLXNB2 NOD2 GHR YTHDF1 ADRA1A HPX PLCB1 BCAR3 NOS1 NOP53 CAPN3 DVL3 LARP1 NLRP1 YBX3 LRRK1 HUWE1 SLC6A9 THPO EIF4G1 PRKD1 GREM1 MARK2 MAPK8 EP300 | 8.61e-05 | 1458 | 221 | 32 | GO:0051247 |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 9.72e-05 | 9 | 221 | 3 | GO:0071608 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | GATAD2A MBNL1 BCOR KLF4 PLXNB2 BIRC6 BAP1 MRTFB YAP1 AMOT GLI2 PRRC2B TCF7 ZFAT CAMSAP3 DVL3 YBX3 NCOR1 OSR1 ANKRD11 NCOA1 PCDH8 EP300 | 1.18e-04 | 906 | 221 | 23 | GO:0043009 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | XIRP1 SIRPB1 SIRPA MRTFB FMN1 AMOT MICAL3 PCLO CAPN3 BRSK2 SHC1 DVL3 PLEKHG2 SLC4A2 ARHGEF10 SIPA1L1 TLN1 CSRP1 TBCK PRKD1 EP300 | 1.57e-04 | 803 | 221 | 21 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | DAB2IP MYCBP2 DAZL PTBP1 ADRA1A NOP53 LARP1 YBX3 TAB3 NCOR1 WDR6 EIF4G1 LAMP3 EP300 | 1.77e-04 | 418 | 221 | 14 | GO:0009895 |
| GeneOntologyBiologicalProcess | negative regulation of GTPase activity | 1.85e-04 | 27 | 221 | 4 | GO:0034260 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | MYCBP2 DISC1 AZGP1 GHR WWC2 SPAAR YAP1 PLCB1 CAPN3 YBX3 NCOR1 DUSP10 RIMS1 EP300 | 1.91e-04 | 421 | 221 | 14 | GO:0048638 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DAB2IP RRP1B SUPT20HL2 POGZ PTBP1 BCL9 KLF4 NOD2 TSC22D1 MRTFB YAP1 GLI2 NFKB2 NOS1 TET3 FUBP3 SERTAD1 ZFAT DVL3 POU2AF1 MLLT10 OSR1 NCOA1 SIX5 MYOCD PRKD1 GREM1 KAT6B MUC1 EP300 | 1.96e-04 | 1390 | 221 | 30 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of translation | 2.29e-04 | 151 | 221 | 8 | GO:0045727 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | GATAD2A MBNL1 BCOR KLF4 BIRC6 BAP1 MRTFB YAP1 AMOT GLI2 PRRC2B ZFAT CAMSAP3 YBX3 NCOR1 ANKRD11 NCOA1 | 2.50e-04 | 596 | 221 | 17 | GO:0001701 |
| GeneOntologyBiologicalProcess | neuron projection development | DAB2IP EPHB6 GAK MYCBP2 KIF26A DISC1 PLXND1 PTBP1 KLF4 PLXNB2 TENM2 YTHDF1 MRTFB GLI2 WHRN CAMSAP3 BRSK2 SHC1 DVL3 SIPA1L1 PRKD1 RIMS1 RERE MARK2 MAPK8 EP300 VPS13B INPP5J | 2.79e-04 | 1285 | 221 | 28 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of phosphate metabolic process | DAB2IP AXL SIRPB1 SIRPA PTBP1 CMYA5 PLXNB2 NOD2 GHR LIME1 ADRA1A HPX BCAR3 MVP NOS1 SERTAD1 NOP53 DVL3 LRRK1 NCOR1 THPO VCAN EIF4G1 MYOCD PRKD1 DUSP10 GREM1 MARK2 EP300 INPP5J | 2.86e-04 | 1421 | 221 | 30 | GO:0019220 |
| GeneOntologyBiologicalProcess | regulation of phosphorus metabolic process | DAB2IP AXL SIRPB1 SIRPA PTBP1 CMYA5 PLXNB2 NOD2 GHR LIME1 ADRA1A HPX BCAR3 MVP NOS1 SERTAD1 NOP53 DVL3 LRRK1 NCOR1 THPO VCAN EIF4G1 MYOCD PRKD1 DUSP10 GREM1 MARK2 EP300 INPP5J | 2.92e-04 | 1423 | 221 | 30 | GO:0051174 |
| GeneOntologyBiologicalProcess | JNK cascade | 2.95e-04 | 198 | 221 | 9 | GO:0007254 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 3.21e-04 | 13 | 221 | 3 | GO:0071349 | |
| GeneOntologyBiologicalProcess | monocyte extravasation | 3.21e-04 | 13 | 221 | 3 | GO:0035696 | |
| GeneOntologyBiologicalProcess | developmental growth | XIRP1 MYCBP2 DISC1 AZGP1 BCL9 GHR WWC2 ADRA1A SPAAR YAP1 FMN1 GLI2 PLCB1 CAPN3 YBX3 NCOR1 ANKRD11 MYOCD DUSP10 RIMS1 EP300 VPS13B | 3.33e-04 | 911 | 221 | 22 | GO:0048589 |
| GeneOntologyBiologicalProcess | actin filament-based process | XIRP1 SIRPB1 SIRPA MRTFB FMN1 AMOT MICAL3 NOS1 PCLO CAPN3 BRSK2 SHC1 DVL3 PLEKHG2 SLC4A2 ARHGEF10 SIPA1L1 TLN1 CSRP1 TBCK PRKD1 EP300 | 3.38e-04 | 912 | 221 | 22 | GO:0030029 |
| GeneOntologyBiologicalProcess | embryo development | GATAD2A MBNL1 SUPT20HL2 ECSIT BCOR MFRP KLF4 PLXNB2 BIRC6 BAP1 MRTFB YAP1 AMOT GLI2 PLCB1 PRRC2B WHRN TCF7 ZFAT CAMSAP3 DVL3 YBX3 YEATS2 NCOR1 OSR1 ANKRD11 NCOA1 GREM1 PCDH8 EP300 | 3.45e-04 | 1437 | 221 | 30 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of JNK cascade | 3.53e-04 | 161 | 221 | 8 | GO:0046328 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DAB2IP GAK MYCBP2 KIF26A DISC1 PLXND1 PTBP1 KLF4 PLXNB2 TENM2 YTHDF1 YAP1 RAP1GAP BRSK2 DVL3 SIPA1L1 PRKD1 MARK2 USP6NL EP300 INPP5J | 4.12e-04 | 863 | 221 | 21 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | EPHB6 DISC1 SIRPB1 SIRPA PLXND1 KLF4 PLXNB2 NOD2 FMN1 GLI2 ZNF703 RAP1GAP CAMSAP3 MFSD2B SLC4A2 TLN1 SMARCC2 DUSP10 GREM1 MUC1 PCDH8 EP300 | 4.21e-04 | 927 | 221 | 22 | GO:0030155 |
| GeneOntologyBiologicalProcess | sarcomere organization | 4.22e-04 | 59 | 221 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | neuron development | DAB2IP EPHB6 GAK MYCBP2 KIF26A DISC1 PLXND1 PTBP1 MFRP KLF4 PLXNB2 TENM2 YTHDF1 MRTFB GLI2 WHRN CAMSAP3 BRSK2 SHC1 DVL3 SIPA1L1 RP1L1 PRKD1 RIMS1 RERE MARK2 MAPK8 EP300 VPS13B INPP5J | 4.65e-04 | 1463 | 221 | 30 | GO:0048666 |
| GeneOntologyBiologicalProcess | Golgi organization | 4.69e-04 | 168 | 221 | 8 | GO:0007030 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway | DAB2IP AMER1 DISC1 BCL9 KLF4 YAP1 ZNF703 TCF7 DVL3 AMER3 LRRK1 CSNK1G2 TLE3 GREM1 MARK2 | 4.75e-04 | 516 | 221 | 15 | GO:0016055 |
| GeneOntologyBiologicalProcess | regulation of protein phosphorylation | DAB2IP SIRPB1 SIRPA PLXNB2 NOD2 GHR LIME1 ADRA1A HPX BCAR3 MVP NOS1 SERTAD1 NOP53 DVL3 LRRK1 THPO EIF4G1 MYOCD PRKD1 DUSP10 GREM1 MARK2 EP300 INPP5J | 5.02e-04 | 1133 | 221 | 25 | GO:0001932 |
| GeneOntologyBiologicalProcess | regulation of tooth mineralization | 5.02e-04 | 15 | 221 | 3 | GO:0070170 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling | 5.02e-04 | 15 | 221 | 3 | GO:0098917 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYCBP2 DAZL PTBP1 NOD2 YAP1 FMN1 G3BP2 BUB1B NAV3 PLCB1 CAMSAP3 DVL3 UPF1 PLEKHG2 HUWE1 SLC4A2 ARHGEF10 SIPA1L1 YLPM1 SASS6 SMARCC2 PRKD1 RIMS1 MARK2 MAPK8 USP6NL EP300 INPP5J | 5.56e-04 | 1342 | 221 | 28 | GO:0033043 |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.69e-05 | 85 | 225 | 7 | GO:0000118 | |
| GeneOntologyCellularComponent | chromatin | GATAD2A RRP1B SUPT20HL2 POGZ KLF4 CIC NFKB2 PLCB1 SAP130 TCF7 EP400 NOP53 BICRA DVL3 ADNP2 TSPYL6 UPF1 YEATS2 NCOR1 OSR1 ANKRD11 NCOA1 HSFX1 SMARCC2 SIX5 DMRTA1 MYOCD BICRAL KAT6B MUC1 EP300 HR | 1.25e-04 | 1480 | 225 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.25e-04 | 13 | 225 | 3 | GO:1990907 | |
| Domain | ZnF_C2HC | 2.64e-06 | 55 | 210 | 7 | SM00343 | |
| Domain | Znf_CCHC | 2.64e-06 | 55 | 210 | 7 | IPR001878 | |
| Domain | MYB_LIKE | 3.85e-06 | 38 | 210 | 6 | PS50090 | |
| Domain | LRRC37AB_C | 5.56e-06 | 4 | 210 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 5.56e-06 | 4 | 210 | 3 | PF14914 | |
| Domain | LRRC37_N | 5.56e-06 | 4 | 210 | 3 | IPR032754 | |
| Domain | LRRC37 | 5.56e-06 | 4 | 210 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 5.56e-06 | 4 | 210 | 3 | IPR015753 | |
| Domain | SANT | 1.98e-05 | 50 | 210 | 6 | SM00717 | |
| Domain | SANT/Myb | 2.49e-05 | 52 | 210 | 6 | IPR001005 | |
| Domain | Myb_DNA-binding | 4.23e-05 | 35 | 210 | 5 | PF00249 | |
| Domain | GSCR1_dom | 1.26e-04 | 2 | 210 | 2 | IPR015671 | |
| Domain | GLTSCR1 | 1.26e-04 | 2 | 210 | 2 | PF15249 | |
| Domain | SANT_dom | 1.91e-04 | 26 | 210 | 4 | IPR017884 | |
| Domain | SANT | 2.57e-04 | 28 | 210 | 4 | PS51293 | |
| Domain | PDZ | 3.14e-04 | 151 | 210 | 8 | PS50106 | |
| Domain | PDZ | 3.28e-04 | 152 | 210 | 8 | IPR001478 | |
| Domain | WTX | 3.75e-04 | 3 | 210 | 2 | PF09422 | |
| Domain | Uncharacterised_FAM123 | 3.75e-04 | 3 | 210 | 2 | IPR019003 | |
| Domain | Ig-like_fold | EPHB6 MYCBP2 AXL AZGP1 SIRPB1 SIRPA PLXND1 CMYA5 PLXNB2 GHR HAVCR1 NFKB2 IL27RA SDK2 SLC4A2 CSF2RB VSTM2L VCAN MADCAM1 | 4.05e-04 | 706 | 210 | 19 | IPR013783 |
| Domain | - | EPHB6 MYCBP2 AXL AZGP1 SIRPB1 SIRPA PLXND1 CMYA5 PLXNB2 GHR HAVCR1 NFKB2 IL27RA SDK2 CSF2RB VSTM2L VCAN MADCAM1 | 5.20e-04 | 663 | 210 | 18 | 2.60.40.10 |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 5.77e-05 | 22 | 139 | 4 | M859 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 6.93e-05 | 23 | 139 | 4 | MM15134 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.25e-05 | 24 | 139 | 4 | M13404 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.14e-04 | 26 | 139 | 4 | MM14793 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.36e-04 | 80 | 139 | 6 | M223 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A8 FAM90A16 FAM90A10 | 3.25e-18 | 25 | 229 | 11 | 17684299 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 MYCBP2 POGZ BCL9 BCOR CIC BAP1 WWC2 GSE1 YAP1 MICAL3 SFSWAP EP400 BAG3 CAMSAP3 LARP1 YBX3 HUWE1 YEATS2 NCOR1 ZNF106 TLE3 SIPA1L1 YLPM1 EIF4G1 SMARCC2 RIMS1 RERE MARK2 SNAPC4 MAPK8 KAT6B CCDC9 | 1.87e-17 | 774 | 229 | 33 | 15302935 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DAB2IP ZXDC MYCBP2 KIF26A PLXND1 BCL9 KLF4 MAST2 PLXNB2 BIRC6 CIC BAP1 NOD2 LIME1 NFKB2 ZNF398 MICAL3 ABCD1 PRRC2B CRYBG2 EP400 BICRA SHC1 LRRK1 HUWE1 MLLT10 MED13L C6orf132 NCOR1 SLC2A4RG CSNK1G2 TLN1 EIF4G1 ANKRD11 SNAPC4 EP300 HR | 4.20e-16 | 1105 | 229 | 37 | 35748872 |
| Pubmed | ZNF536 GATAD2A RRP1B SEC24A MBNL1 POGZ BCL9 BCOR KLF4 CIC BAP1 YTHDF1 GSE1 YAP1 GLI2 G3BP2 NFKB2 SAP130 FUBP3 PRRC2B ZNF703 TCF7 EP400 PITRM1 NOP53 BICRA LARP1 YBX3 UPF1 MLLT10 TAB3 YEATS2 NCOR1 TLE3 YLPM1 EIF4G1 NCOA1 SMARCC2 SIX5 RERE EP300 | 1.76e-15 | 1429 | 229 | 41 | 35140242 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A8 FAM90A16 FAM90A10 | 1.50e-14 | 23 | 229 | 9 | 18602769 | |
| Pubmed | STAM2 HBS1L GAK MYCBP2 POGZ BCOR MRTFB YAP1 AMOT BUB1B SAP130 PRRC2B EP400 BAG3 LARP1 UPF1 HUWE1 TAB3 YEATS2 NCOR1 WDR6 TLN1 YLPM1 EP300 | 3.47e-13 | 549 | 229 | 24 | 38280479 | |
| Pubmed | DAB2IP ZNF536 POGZ TENM2 RUSC2 GSE1 NAV3 MICAL3 TET3 PRRC2B WHRN EP400 FRMPD1 MED13L YEATS2 CADPS TLE3 SIPA1L1 TLN1 RERE VPS13B | 4.82e-13 | 407 | 229 | 21 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | STAM2 AMER1 MYCBP2 SEC24A MAST2 CIC RUSC2 WWC2 YAP1 AMOT BUB1B NHS RAP1GAP BAG3 CAMSAP3 BRSK2 LARP1 PLEKHG2 ZNRF2 TAB3 C6orf132 ZNF106 ARHGEF10 SIPA1L1 EIF4G1 ANKRD11 MARK2 KIF13A USP6NL | 7.34e-13 | 861 | 229 | 29 | 36931259 |
| Pubmed | BCL9 BCOR KLF4 CIC BAP1 GSE1 YAP1 SAP130 PRRC2B EP400 MED13L NCOR1 TLE3 YLPM1 NCOA1 SMARCC2 RERE | 3.34e-12 | 268 | 229 | 17 | 33640491 | |
| Pubmed | ZNF536 MYCBP2 POGZ BCOR BIRC6 CIC BAP1 MRTFB GSE1 AMOT BUB1B BAG3 CAMSAP3 DVL3 HUWE1 YEATS2 NCOR1 WDR6 TLE3 RERE | 6.97e-12 | 418 | 229 | 20 | 34709266 | |
| Pubmed | ZNF536 POGZ BCL9 BCOR CIC GSE1 SAP130 EP400 NCOR1 TLE3 EP300 | 8.44e-12 | 83 | 229 | 11 | 28794006 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | HBS1L GATAD2A POGZ BCOR ZNF703 EP400 BICRA PCLO ADNP2 LARP1 NLRP1 FAM90A1 YEATS2 TLE3 NCOA1 SMARCC2 SIX5 BICRAL EP300 | 2.48e-11 | 398 | 229 | 19 | 35016035 |
| Pubmed | ZNF536 TRPC4AP GATAD2A LRRC37A3 AXL MC3R BCL9 BCOR CIC CCDC85A GSE1 G3BP2 TRIM8 PLCB1 PRRC2B TCF7 PPFIA3 YEATS2 NCOR1 TLE3 NCOA1 SMARCC2 EP300 | 5.34e-11 | 638 | 229 | 23 | 31182584 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | AOC1 FAM90A14 FAM90A17 NFKB2 FAM90A19 FAM90A1 FAM90A22 FAM90A26 FAM90A23 FAM90A7 MUC1 FAM90A8 FAM90A10 | 7.91e-11 | 164 | 229 | 13 | 22967998 |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF536 POGZ BCL9 BCOR DUXB GSE1 PRRC2B ZNF703 EP400 BICRA NCOR1 WDR6 TLE3 NCOA1 SMARCC2 RERE EP300 | 2.30e-10 | 351 | 229 | 17 | 38297188 |
| Pubmed | DAB2IP MYCBP2 BIRC6 BAP1 MRTFB AMOT PLCB1 PPFIA3 MED13L ARHGEF10 CADPS SIPA1L1 TLN1 KAT6B | 3.67e-10 | 225 | 229 | 14 | 12168954 | |
| Pubmed | BCL9 BCOR CIC GSE1 AMOT TRIM8 PRRC2B ZNF703 BICRA TAB3 NCOA1 EP300 | 4.50e-10 | 152 | 229 | 12 | 38360978 | |
| Pubmed | DAB2IP MYCBP2 RUSC2 G3BP2 PLCB1 MICAL3 PCLO CAMSAP3 BRSK2 SLC1A4 C1orf198 SIPA1L1 CSRP1 RIMS1 MARK2 JPH3 | 1.60e-09 | 347 | 229 | 16 | 17114649 | |
| Pubmed | DAB2IP STAM2 RRP1B MYCBP2 SEC24A BCOR BIRC6 CIC WWC2 GSE1 NHS MICAL3 PRRC2B ZNF703 NOP53 BAG3 CAMSAP3 SHC1 HUWE1 PPFIA3 TAB3 NCOR1 PTPDC1 TLE3 YLPM1 DUSP10 MAPK8 | 1.86e-09 | 1049 | 229 | 27 | 27880917 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | MBNL1 BCL9 BCOR GSE1 YAP1 FUBP3 ZNF703 SLC6A9 NCOR1 YLPM1 MARK2 USP6NL | 3.12e-09 | 180 | 229 | 12 | 35198878 |
| Pubmed | GATAD2A MYCBP2 MBNL1 POGZ PTBP1 BCL9 BCOR CIC GSE1 G3BP2 SAP130 FUBP3 PRRC2B EP400 BICRA LARP1 UPF1 MED13L YEATS2 NCOR1 ERGIC3 TLE3 TLN1 NCOA1 SMARCC2 BICRAL EP300 | 5.38e-09 | 1103 | 229 | 27 | 34189442 | |
| Pubmed | DAB2IP MYCBP2 WDR81 SIRPB1 SIRPA BCL9 BCOR TENM2 G3BP2 PLCB1 NOS1 PRRC2B CAMSAP3 UPF1 HUWE1 PPFIA3 NCOR1 ZC2HC1A SIPA1L1 YLPM1 EIF4G1 SMARCC2 PRKD1 RIMS1 PCDH8 | 6.52e-09 | 963 | 229 | 25 | 28671696 | |
| Pubmed | 6.53e-09 | 87 | 229 | 9 | 12465718 | ||
| Pubmed | DAB2IP GATAD2A RRP1B YAP1 NHS BCAR3 BAG3 CAMSAP3 LARP1 HUWE1 NCOR1 ZC2HC1A TLE3 CSRP1 EIF4G1 MARK2 KIF13A | 4.87e-08 | 503 | 229 | 17 | 16964243 | |
| Pubmed | DAB2IP MYCBP2 PTBP1 BIRC6 TENM2 YTHDF1 G3BP2 NAV3 PLCB1 NOS1 PCLO CAMSAP3 BRSK2 DVL3 HUWE1 PPFIA3 SLC1A4 TAB3 C1orf198 CADPS SIPA1L1 SMARCC2 RIMS1 PCDH8 JPH3 | 1.65e-07 | 1139 | 229 | 25 | 36417873 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | MBNL1 PTBP1 CMYA5 YTHDF1 G3BP2 FUBP3 PRRC2B LARP1 YBX3 UPF1 EIF4G1 CCDC9 | 1.68e-07 | 258 | 229 | 12 | 37794589 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRPC4AP AMER1 MYCBP2 MBNL1 TSC22D1 MRTFB GLI2 MICAL3 SAP130 TET3 BICRA FRMPD1 CAMSAP3 LARP1 HUWE1 LRRC8D LRCH3 YEATS2 PTPDC1 TLE3 VSTM2L TBCK ANKRD11 PRKD1 RIMS1 RERE KAT6B EP300 VPS13B | 1.98e-07 | 1489 | 229 | 29 | 28611215 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZBTB48 DISC1 BCL9 CIC MRTFB YAP1 GLI2 SAP130 EP400 BICRA MLLT10 C6orf132 NCOR1 TLN1 YLPM1 | 2.04e-07 | 430 | 229 | 15 | 35044719 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | GATAD2A RRP1B MBNL1 POGZ PTBP1 BCOR CIC YTHDF1 SAP130 FUBP3 SFSWAP EP400 NOP53 BICRA LARP1 YBX3 YEATS2 NCOR1 YLPM1 EIF4G1 ANKRD11 SMARCC2 | 4.20e-07 | 954 | 229 | 22 | 36373674 |
| Pubmed | ZNF536 GATAD2A RIBC2 POGZ SIRPB1 BCOR MAST2 GSE1 SAP130 PRRC2B SFSWAP EP400 BICRA ADNP2 PPFIA3 YEATS2 CADPS WDR6 SIPA1L1 SMARCC2 BICRAL RERE KAT6B EP300 | 4.27e-07 | 1116 | 229 | 24 | 31753913 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | SEC24A MBNL1 BCL9 BCOR CIC YTHDF1 GSE1 SAP130 FUBP3 PRRC2B YEATS2 NCOR1 TLE3 YLPM1 EP300 | 4.42e-07 | 457 | 229 | 15 | 32344865 |
| Pubmed | 4.55e-07 | 24 | 229 | 5 | 33722704 | ||
| Pubmed | 4.68e-07 | 104 | 229 | 8 | 9205841 | ||
| Pubmed | XIRP1 KIF26A YTHDF1 TSGA10IP TET3 PHF21B WHRN ZFAT NCOR1 NCOA1 SIX5 | 4.78e-07 | 233 | 229 | 11 | 37704626 | |
| Pubmed | PTBP1 BCOR AMOT SAP130 FUBP3 ZNF703 SFSWAP BICRA BAG3 LARP1 VTA1 TLE3 YLPM1 SMARCC2 | 4.89e-07 | 399 | 229 | 14 | 35987950 | |
| Pubmed | STAM2 PTBP1 BCOR CIC HAVCR1 FUBP3 PRRC2B SERTAD1 BEND2 NCOR1 VSTM2L HSFX1 SMARCC2 SIX5 RERE KAT6B PCDH8 | 6.98e-07 | 608 | 229 | 17 | 16713569 | |
| Pubmed | 8.69e-07 | 78 | 229 | 7 | 28611094 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | AMER1 RRP1B MYCBP2 MAST2 GHR GSE1 PRRC2B SDK2 NOP53 BAG3 YBX3 VSTM2L EIF4G1 | 9.46e-07 | 361 | 229 | 13 | 26167880 |
| Pubmed | 1.08e-06 | 116 | 229 | 8 | 30804394 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 22419166 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | AMER1 RRP1B YTHDF1 AMOT BUB1B SERTAD1 PCLO LARP1 YBX3 HUWE1 PPFIA3 FAM90A1 LRCH3 ITPKC WDR6 MARK2 EP300 | 1.37e-06 | 639 | 229 | 17 | 23443559 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | DAB2IP STAM2 HBS1L AMER1 SEC24A WDR81 POGZ RUSC2 YTHDF1 WWC2 MRTFB YAP1 NFKB2 BUB1B RAP1GAP SHC1 DVL3 UPF1 ZNRF2 PTPDC1 C1orf198 ZC2HC1A | 1.68e-06 | 1038 | 229 | 22 | 26673895 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | HBS1L GATAD2A AZGP1 BCOR EP400 LARP1 UPF1 YEATS2 NCOR1 ZNF106 C1orf198 TLE3 TLN1 EIF4G1 | 1.72e-06 | 444 | 229 | 14 | 34795231 |
| Pubmed | ZXDC ZBTB48 MBNL1 POGZ KLF4 CIC TSC22D1 NFKB2 ZNF398 TCF7 MLLT10 NCOR1 ZC2HC1A TLE3 CSRP1 OSR1 NCOA1 SNAPC4 KAT6B | 2.01e-06 | 808 | 229 | 19 | 20412781 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | STAM2 GAK ZCCHC2 BCOR CIC MRTFB GSE1 YAP1 NFKB2 PRRC2B ZNF703 EP400 HUWE1 YEATS2 NCOR1 SASS6 | 2.12e-06 | 588 | 229 | 16 | 38580884 |
| Pubmed | RRP1B PTBP1 AMOT G3BP2 FUBP3 LARP1 UPF1 SIPA1L1 EIF4G1 SMARCC2 MARK2 | 2.33e-06 | 274 | 229 | 11 | 34244482 | |
| Pubmed | RRP1B KIF26A POGZ PLXND1 BCOR BAP1 AMOT PLCB1 SDK2 EP400 PITRM1 LARP1 LRRK1 KAT6B USP6NL | 2.70e-06 | 529 | 229 | 15 | 14621295 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MYCBP2 MBNL1 MAST2 TENM2 YTHDF1 G3BP2 PRRC2B PCLO LARP1 YBX3 UPF1 YLPM1 EIF4G1 PRKD1 | 2.73e-06 | 462 | 229 | 14 | 31138677 |
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 14985122 | ||
| Pubmed | GAK PTBP1 AMOT G3BP2 MICAL3 NOS1 PRRC2B RAP1GAP PCLO CAMSAP3 BRSK2 LARP1 UPF1 PPFIA3 SLC1A4 LRCH3 ZC2HC1A CADPS SIPA1L1 VCAN TLN1 CSRP1 EIF4G1 SMARCC2 RIMS1 MARK2 | 3.17e-06 | 1431 | 229 | 26 | 37142655 | |
| Pubmed | STAM2 GATAD2A SEC24A AZGP1 CIC BUB1B SAP130 FUBP3 EP400 YEATS2 C1orf198 TLE3 CSRP1 SASS6 | 3.50e-06 | 472 | 229 | 14 | 38943005 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | HBS1L ZBTB48 LRRC37A3 ECSIT PLXNB2 GSE1 YAP1 PLCB1 RAP1GAP SLC4A2 PTPDC1 C1orf198 SLC2A4RG ERGIC3 CSNK1G2 TLE3 TLN1 EIF4G1 MARK2 KIF13A | 3.80e-06 | 925 | 229 | 20 | 28986522 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF536 GATAD2A POGZ CIC BAP1 GSE1 NFKB2 SAP130 FUBP3 EP400 FRMPD1 LARP1 HUWE1 NCOR1 TLE3 EIF4G1 SMARCC2 SIX5 EP300 | 4.69e-06 | 857 | 229 | 19 | 25609649 |
| Pubmed | KIF26A POGZ CIC TSC22D1 NAV3 PLCB1 BICRA BAG3 ADNP2 ZNF106 BICRAL DUSP10 MUC1 EP300 | 4.88e-06 | 486 | 229 | 14 | 20936779 | |
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 17468099 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP SIRPA MRTFB YAP1 FMN1 NHS BAG3 DVL3 LARP1 C6orf132 C1orf198 TLN1 EIF4G1 MARK2 USP6NL | 5.96e-06 | 565 | 229 | 15 | 25468996 |
| Pubmed | DAB2IP GAK AMOT G3BP2 FRMPD1 CAMSAP3 LARP1 UPF1 PPFIA3 SIPA1L1 VCAN MARK2 JPH3 | 6.40e-06 | 430 | 229 | 13 | 32581705 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYCBP2 MBNL1 POGZ YTHDF1 AMOT G3BP2 FUBP3 PRRC2B ZNF703 DVL3 LARP1 YBX3 UPF1 WDR6 TLN1 YLPM1 EIF4G1 | 7.19e-06 | 724 | 229 | 17 | 36232890 |
| Pubmed | RRP1B MYCBP2 POGZ BIRC6 MVP FUBP3 PRRC2B NOP53 LARP1 UPF1 HUWE1 WDR6 TLN1 YLPM1 EIF4G1 SMARCC2 | 7.95e-06 | 653 | 229 | 16 | 22586326 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | HBS1L RRP1B MYCBP2 AMOT G3BP2 EP400 LARP1 UPF1 HUWE1 LRCH3 WDR6 YLPM1 SMARCC2 | 8.17e-06 | 440 | 229 | 13 | 34244565 |
| Pubmed | AMER1 RRP1B PTBP1 YAP1 G3BP2 NHS MVP TCF7 BAG3 SHC1 DVL3 LARP1 UPF1 HUWE1 MED13L NCOR1 ZC2HC1A SIPA1L1 TLN1 EIF4G1 SMARCC2 MARK2 CCDC9 | 9.55e-06 | 1247 | 229 | 23 | 27684187 | |
| Pubmed | Growth hormone regulation of SIRP and SHP-2 tyrosyl phosphorylation and association. | 9.67e-06 | 7 | 229 | 3 | 9507023 | |
| Pubmed | SEC24A AMOT NHS FUBP3 PRRC2B DVL3 TAB3 C6orf132 USP6NL VPS13B | 1.08e-05 | 263 | 229 | 10 | 34702444 | |
| Pubmed | IRAK2 PRRC2B LARP1 HUWE1 YEATS2 ARHGEF10 WDR6 TLN1 EIF4G1 ANKRD11 EP300 | 1.43e-05 | 332 | 229 | 11 | 37433992 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | HBS1L AMER1 SEC24A MAST2 MRTFB PROSER3 BUB1B MICAL3 PRRC2B CAMSAP3 PLEKHG2 TAB3 NCOR1 C1orf198 ZC2HC1A SIPA1L1 TLN1 SASS6 | 1.63e-05 | 853 | 229 | 18 | 28718761 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.69e-05 | 220 | 229 | 9 | 35785414 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | HBS1L RRP1B AZGP1 WDR81 PTBP1 EP400 LARP1 YBX3 HUWE1 MED13L FAM90A1 WDR6 TLE3 SIPA1L1 MAPK8 EP300 | 1.71e-05 | 695 | 229 | 16 | 23602568 |
| Pubmed | GATAD2A RRP1B POGZ BCOR GSE1 SAP130 ZNF703 EP400 NOP53 YEATS2 TLE3 | 1.74e-05 | 339 | 229 | 11 | 30415952 | |
| Pubmed | 1.78e-05 | 49 | 229 | 5 | 31762063 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.82e-05 | 123 | 229 | 7 | 26912792 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | POGZ MRTFB GSE1 YAP1 SAP130 EP400 NCOR1 TLE3 YLPM1 SMARCC2 KAT6B | 1.83e-05 | 341 | 229 | 11 | 32971831 |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | ZXDC TRPC4AP ZBTB48 MAST2 PLXNB2 CIC CCDC85A TSC22D1 YAP1 RAP1GAP CAMSAP3 SHC1 DVL3 LARP1 UPF1 CSNK1G2 EIF4G1 DUSP10 SNAPC4 MAPK8 PCDH8 | 1.96e-05 | 1124 | 229 | 21 | 21900206 |
| Pubmed | RRP1B DISC1 PTBP1 G3BP2 FUBP3 PRRC2B CAMSAP3 LARP1 YBX3 UPF1 HUWE1 TAB3 EIF4G1 CCDC9 | 1.99e-05 | 551 | 229 | 14 | 34728620 | |
| Pubmed | ZXDC ZNF536 MBNL1 POGZ KLF4 BIRC6 CIC GLI2 TRIM8 SERTAD1 TCF7 MLLT10 OSR1 NCOA1 SIX5 KAT6B | 2.18e-05 | 709 | 229 | 16 | 22988430 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | YTHDF1 SPATA33 G3BP2 RAP1GAP BAG3 VTA1 PPFIA3 LRCH3 ZC2HC1A CADPS TLN1 CSRP1 RIMS1 MARK2 | 2.28e-05 | 558 | 229 | 14 | 35063084 |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | GATAD2A MYCBP2 GSE1 SAP130 YBX3 HUWE1 NCOR1 YLPM1 ANKRD11 RERE | 2.44e-05 | 289 | 229 | 10 | 23752268 |
| Pubmed | 2.60e-05 | 130 | 229 | 7 | 12421765 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | ZXDC GATAD2A MYCBP2 POGZ BCOR BAP1 GSE1 ZNF703 NOP53 ADNP2 YEATS2 EIF4G1 RERE | 2.81e-05 | 495 | 229 | 13 | 27705803 |
| Pubmed | BCL9 CIC AMOT SFSWAP BICRA PCLO BAG3 UPF1 NCOR1 C1orf198 SMARCC2 EP300 | 2.85e-05 | 425 | 229 | 12 | 24999758 | |
| Pubmed | HBS1L MAST2 RUSC2 GSE1 BUB1B CARD6 MICAL3 PRRC2B RAP1GAP CAMSAP3 LARP1 SLC4A2 WDR6 MARK2 HR | 3.06e-05 | 650 | 229 | 15 | 38777146 | |
| Pubmed | ZNF536 GAK MYCBP2 BIRC6 YTHDF1 PROSER3 YAP1 EP400 LARP1 HUWE1 SLC4A2 YEATS2 ZNF106 ARHGEF10 WDR6 YLPM1 | 3.25e-05 | 733 | 229 | 16 | 34672954 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | GATAD2A MBNL1 WDR81 SUPT20HL2 MAST2 BIRC6 NHS CAPN3 ZNF106 TBCK EP300 | 3.25e-05 | 363 | 229 | 11 | 14691545 |
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 12738788 | ||
| Pubmed | 3.27e-05 | 10 | 229 | 3 | 23064749 | ||
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 3.27e-05 | 10 | 229 | 3 | 30595551 | |
| Pubmed | GATAD2A RRP1B PTBP1 GSE1 G3BP2 SAP130 PRRC2B ZNF703 BAG3 CAMSAP3 LARP1 YBX3 UPF1 YLPM1 RERE | 3.34e-05 | 655 | 229 | 15 | 35819319 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DISC1 BIRC6 ADRA1A GSE1 AMOT FUBP3 ZNF703 PCLO CAMSAP3 LARP1 TSPYL6 AMER3 HUWE1 PPFIA3 CSNK1G2 TLN1 | 3.41e-05 | 736 | 229 | 16 | 29676528 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZBTB48 KLF4 CIC BNC1 TSC22D1 GLI2 NFKB2 ZNF398 ZNF541 TCF7 ADNP2 YBX3 YEATS2 NCOA1 SIX5 DMRTA1 RERE SNAPC4 | 3.68e-05 | 908 | 229 | 18 | 19274049 |
| Pubmed | 3.75e-05 | 57 | 229 | 5 | 38223760 | ||
| Pubmed | 3.82e-05 | 138 | 229 | 7 | 30320910 | ||
| Pubmed | DAB2IP MBNL1 ZCCHC2 BCOR PLXNB2 PRRC2B CRYBG2 VTA1 FICD SIPA1L1 KAT6B | 3.96e-05 | 371 | 229 | 11 | 15747579 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21730182 | ||
| Pubmed | Involvement of YTHDF1 in renal fibrosis progression via up-regulating YAP. | 4.32e-05 | 2 | 229 | 2 | 34990050 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 38709923 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20610440 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 14645524 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 25100730 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 34548488 | ||
| Pubmed | Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. | 4.32e-05 | 2 | 229 | 2 | 28464980 | |
| Pubmed | YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC. | 4.32e-05 | 2 | 229 | 2 | 29136529 | |
| Interaction | SP7 interactions | ZNF536 MBNL1 POGZ BCL9 BCOR CIC GSE1 SAP130 FUBP3 PRRC2B ZNF703 EP400 PITRM1 BICRA NCOR1 TLE3 YLPM1 NCOA1 SMARCC2 RERE EP300 | 1.38e-11 | 304 | 215 | 21 | int:SP7 |
| Interaction | GCM1 interactions | ZNF536 BCL9 BCOR CIC YTHDF1 GSE1 PRRC2B NCOR1 TLE3 SMARCC2 EP300 | 1.42e-10 | 68 | 215 | 11 | int:GCM1 |
| Interaction | HNF1B interactions | ZNF536 POGZ BCL9 BCOR CIC BAP1 GSE1 YAP1 SAP130 PRRC2B EP400 BICRA MLLT10 NCOR1 TLE3 EP300 | 2.26e-10 | 190 | 215 | 16 | int:HNF1B |
| Interaction | SMG7 interactions | DAZL SIRPA BCL9 BCOR YTHDF1 GSE1 AMOT FUBP3 PRRC2B ZNF703 YBX3 UPF1 MLLT10 YEATS2 NCOR1 ZNF106 TLE3 YLPM1 NCOA1 SNAPC4 | 2.44e-10 | 319 | 215 | 20 | int:SMG7 |
| Interaction | TBXT interactions | ZNF536 POGZ BCL9 BCOR CIC GSE1 YAP1 SAP130 ZNF703 NCOR1 TLE3 SMARCC2 EP300 | 3.38e-10 | 116 | 215 | 13 | int:TBXT |
| Interaction | FEV interactions | POGZ BCL9 BCOR CIC BAP1 GSE1 YAP1 PRRC2B ZNF703 EP400 BICRA MLLT10 NCOR1 TLE3 SIX5 EP300 | 6.02e-10 | 203 | 215 | 16 | int:FEV |
| Interaction | TOP3B interactions | DAB2IP ZXDC MYCBP2 KIF26A SEC24A DAZL PLXND1 BCL9 KLF4 MAST2 PLXNB2 BIRC6 CIC BAP1 NOD2 YTHDF1 LIME1 G3BP2 NFKB2 ZNF398 MICAL3 ABCD1 FUBP3 PRRC2B CRYBG2 EP400 BICRA SHC1 UPF1 LRRK1 HUWE1 MLLT10 MED13L C6orf132 NCOR1 SLC2A4RG CSNK1G2 TLN1 EIF4G1 ANKRD11 SNAPC4 EP300 HR | 1.11e-09 | 1470 | 215 | 43 | int:TOP3B |
| Interaction | PAX9 interactions | ZNF536 MBNL1 BCL9 BCOR KLF4 CIC GSE1 SAP130 FUBP3 ZNF703 NCOR1 TLE3 EP300 | 1.41e-09 | 130 | 215 | 13 | int:PAX9 |
| Interaction | KLF5 interactions | BCL9 BCOR CIC BAP1 GSE1 YAP1 FUBP3 PRRC2B EP400 NOP53 LARP1 MLLT10 NCOR1 TLE3 EP300 | 2.95e-09 | 195 | 215 | 15 | int:KLF5 |
| Interaction | KLF15 interactions | RRP1B POGZ BCL9 BCOR CIC GSE1 YAP1 GLI2 SAP130 PRRC2B EP400 NOP53 DVL3 LARP1 NCOR1 NCOA1 EP300 | 1.56e-08 | 290 | 215 | 17 | int:KLF15 |
| Interaction | RCOR1 interactions | ZNF536 GATAD2A MYCBP2 BCOR KLF4 BIRC6 CIC BAP1 MRTFB GSE1 AMOT BUB1B PHF21B BAG3 CAMSAP3 DVL3 VTA1 HUWE1 YEATS2 NCOR1 WDR6 SMARCC2 | 1.76e-08 | 494 | 215 | 22 | int:RCOR1 |
| Interaction | ERG interactions | BCL9 BCOR CIC GSE1 TRIM8 PRRC2B ZNF703 BICRA HUWE1 MLLT10 NCOR1 TLE3 SMARCC2 RERE EP300 | 1.82e-08 | 223 | 215 | 15 | int:ERG |
| Interaction | YWHAH interactions | DAB2IP STAM2 AMER1 MYCBP2 SEC24A MAST2 CIC BAP1 RUSC2 WWC2 YAP1 AMOT NHS RAP1GAP SFSWAP BAG3 CAMSAP3 LARP1 PLEKHG2 HUWE1 ZNRF2 TAB3 C6orf132 ZNF106 PTPDC1 SIPA1L1 EIF4G1 ANKRD11 NCOA1 PRKD1 RIMS1 GREM1 MARK2 USP6NL | 2.25e-08 | 1102 | 215 | 34 | int:YWHAH |
| Interaction | GATA2 interactions | ZNF536 BCL9 BCOR CIC BAP1 GSE1 SAP130 PRRC2B ZNF703 POU2AF1 NCOR1 TLE3 SMARCC2 EP300 | 3.13e-08 | 199 | 215 | 14 | int:GATA2 |
| Interaction | TBR1 interactions | ZNF536 MYCBP2 BCL9 BCOR CIC BAP1 GSE1 ZNF703 NCOR1 TLE3 EP300 | 3.54e-08 | 113 | 215 | 11 | int:TBR1 |
| Interaction | TLX1 interactions | ZNF536 POGZ BCL9 BCOR CIC BAP1 GSE1 G3BP2 SAP130 ZNF703 NCOR1 TLE3 EP300 | 5.19e-08 | 175 | 215 | 13 | int:TLX1 |
| Interaction | EYA4 interactions | BCL9 BCOR CIC GSE1 AMOT TRIM8 PRRC2B ZNF703 BICRA BAG3 DVL3 TAB3 NCOA1 SIX5 EP300 | 5.70e-08 | 243 | 215 | 15 | int:EYA4 |
| Interaction | HDAC1 interactions | ZNF536 GATAD2A MYCBP2 BCOR KLF4 BIRC6 CIC BAP1 MRTFB GSE1 YAP1 AMOT GLI2 BUB1B SAP130 PHF21B EP400 BAG3 CAMSAP3 EID2B DVL3 VTA1 LRCH3 YEATS2 NCOR1 WDR6 TLE3 TLN1 SMARCC2 RERE MAPK8 EP300 HR | 8.53e-08 | 1108 | 215 | 33 | int:HDAC1 |
| Interaction | ALG13 interactions | DAZL BCL9 BCOR YTHDF1 GSE1 FUBP3 PRRC2B ZNF703 UPF1 NCOR1 TLE3 RERE EP300 | 8.79e-08 | 183 | 215 | 13 | int:ALG13 |
| Interaction | DTX2 interactions | MBNL1 POGZ BCL9 ECSIT BCOR GSE1 YAP1 MVP FUBP3 ZNF703 SLC6A9 NCOR1 YLPM1 EIF4G1 BICRAL MARK2 USP6NL | 1.02e-07 | 330 | 215 | 17 | int:DTX2 |
| Interaction | YWHAG interactions | DAB2IP STAM2 AMER1 MYCBP2 DISC1 SEC24A MAST2 CIC BAP1 RUSC2 WWC2 YAP1 AMOT NHS RAP1GAP BAG3 CAMSAP3 SHC1 LARP1 PLEKHG2 HUWE1 ZNRF2 TAB3 C6orf132 LRCH3 ZNF106 PTPDC1 SIPA1L1 HSPB6 EIF4G1 ANKRD11 PRKD1 MARK2 KIF13A USP6NL | 1.42e-07 | 1248 | 215 | 35 | int:YWHAG |
| Interaction | WWTR1 interactions | STAM2 HBS1L GAK MYCBP2 POGZ BCOR YAP1 AMOT PRRC2B EP400 BAG3 DVL3 LARP1 TAB3 YEATS2 NCOR1 WDR6 TLN1 EP300 | 1.47e-07 | 422 | 215 | 19 | int:WWTR1 |
| Interaction | EN1 interactions | 2.87e-07 | 110 | 215 | 10 | int:EN1 | |
| Interaction | PAX8 interactions | 3.13e-07 | 111 | 215 | 10 | int:PAX8 | |
| Interaction | EGR2 interactions | ZNF536 POGZ BCL9 BCOR PRRC2B EP400 BICRA NCOR1 TLE3 NCOA1 RERE EP300 | 3.18e-07 | 171 | 215 | 12 | int:EGR2 |
| Interaction | SOX15 interactions | 3.45e-07 | 141 | 215 | 11 | int:SOX15 | |
| Interaction | FOXI1 interactions | 6.11e-07 | 92 | 215 | 9 | int:FOXI1 | |
| Interaction | TLE3 interactions | SEC24A MBNL1 BCL9 BCOR CIC BAP1 GSE1 GLI2 SAP130 ZNF703 MLLT10 NCOR1 TLE3 NCOA1 SMARCC2 RERE EP300 | 6.43e-07 | 376 | 215 | 17 | int:TLE3 |
| Interaction | YWHAQ interactions | DAB2IP STAM2 MYCBP2 DISC1 SEC24A MAST2 CIC BAP1 RUSC2 WWC2 YAP1 NHS RAP1GAP CAPN3 BAG3 CAMSAP3 LARP1 UPF1 ZNRF2 TAB3 C6orf132 ZNF106 PTPDC1 SIPA1L1 TLN1 EIF4G1 MTNR1B NCOA1 PRKD1 MARK2 USP6NL | 1.03e-06 | 1118 | 215 | 31 | int:YWHAQ |
| Interaction | KLF3 interactions | ZNF536 GATAD2A POGZ BCOR CIC GSE1 SAP130 EP400 PITRM1 DVL3 NCOR1 TLE3 EP300 | 1.10e-06 | 228 | 215 | 13 | int:KLF3 |
| Interaction | MYOD1 interactions | BCL9 BCOR BAP1 GSE1 EP400 HUWE1 NCOR1 TLE3 NCOA1 SMARCC2 MYOCD EP300 | 1.22e-06 | 194 | 215 | 12 | int:MYOD1 |
| Interaction | KLF8 interactions | POGZ BCOR CIC BAP1 G3BP2 SAP130 PRRC2B EP400 PITRM1 NOP53 BICRA LARP1 YEATS2 EIF4G1 EP300 | 2.70e-06 | 329 | 215 | 15 | int:KLF8 |
| Interaction | SOX2 interactions | ZNF536 GATAD2A RRP1B AZGP1 POGZ PTBP1 BCL9 BCOR MAST2 CIC YTHDF1 GSE1 YAP1 G3BP2 HPX NAV3 NOS1 SAP130 FUBP3 PRRC2B EP400 NOP53 BAG3 LARP1 UPF1 MED13L NCOR1 ZC2HC1A TLE3 SIPA1L1 YLPM1 SMARCC2 MARK2 KAT6B EP300 | 2.93e-06 | 1422 | 215 | 35 | int:SOX2 |
| Interaction | BAG2 interactions | GAK AXL DISC1 MBNL1 BCOR CIC BAP1 MRTFB YAP1 AMOT BUB1B ZNF703 BAG3 LRRK1 HUWE1 YEATS2 NCOR1 ARHGEF10 TLN1 EP300 VPS13B | 3.46e-06 | 622 | 215 | 21 | int:BAG2 |
| Interaction | PAX2 interactions | 3.50e-06 | 85 | 215 | 8 | int:PAX2 | |
| Interaction | FXR1 interactions | MYCBP2 BCOR BAP1 RUSC2 YTHDF1 YAP1 G3BP2 KCNN1 MVP FUBP3 PRRC2B SERTAD1 CAPN3 UPF1 PPFIA3 FAM90A1 NCOR1 PTPDC1 EIF4G1 SMARCC2 PRKD1 EP300 | 3.89e-06 | 679 | 215 | 22 | int:FXR1 |
| Interaction | UBAP2L interactions | DISC1 DAZL ZCCHC2 BCOR BAP1 YTHDF1 YAP1 G3BP2 FUBP3 PRRC2B BAG3 UPF1 YEATS2 MTNR1B | 4.14e-06 | 298 | 215 | 14 | int:UBAP2L |
| Interaction | YWHAZ interactions | DAB2IP MYCBP2 AXL DISC1 SEC24A AZGP1 BCOR MAST2 CIC BAP1 RUSC2 WWC2 YAP1 NHS NOS1 RAP1GAP BAG3 CAMSAP3 LARP1 HUWE1 PPFIA3 TAB3 C6orf132 NCOR1 PTPDC1 CSF2RB SIPA1L1 HSPB6 PRKD1 MARK2 MAPK8 USP6NL EP300 | 4.15e-06 | 1319 | 215 | 33 | int:YWHAZ |
| Interaction | LHX2 interactions | ZNF536 RRP1B POGZ BCL9 BCOR CIC EP400 NOP53 BEND2 NCOR1 SMARCC2 | 4.52e-06 | 183 | 215 | 11 | int:LHX2 |
| Interaction | PPP2R2A interactions | ECSIT CIC NOD2 GLI2 SERTAD1 SFSWAP SHC1 VTA1 HUWE1 PPFIA3 PTPDC1 DUSP10 CCDC9 HR | 4.65e-06 | 301 | 215 | 14 | int:PPP2R2A |
| Interaction | MEX3B interactions | RUSC2 YTHDF1 PROSER3 G3BP2 FUBP3 PRRC2B RAP1GAP CAMSAP3 DVL3 YBX3 UPF1 WDR6 | 4.97e-06 | 222 | 215 | 12 | int:MEX3B |
| Interaction | SFN interactions | MYCBP2 MAST2 BAP1 RUSC2 WWC2 YAP1 AMOT G3BP2 NHS SAP130 RAP1GAP CAMSAP3 SHC1 LARP1 TAB3 C6orf132 ARHGEF10 SIPA1L1 EIF4G1 MARK2 KIF13A USP6NL | 5.26e-06 | 692 | 215 | 22 | int:SFN |
| Interaction | NR3C1 interactions | ZNF536 TRPC4AP GATAD2A LRRC37A3 AXL MC3R POGZ BCL9 BCOR CIC CCDC85A BAP1 GSE1 G3BP2 NFKB2 TRIM8 PLCB1 PRRC2B TCF7 PPFIA3 YEATS2 NCOR1 TLE3 NCOA1 SMARCC2 MAPK8 EP300 | 5.51e-06 | 974 | 215 | 27 | int:NR3C1 |
| Interaction | GATA3 interactions | ZNF536 BCL9 BCOR CIC GSE1 FUBP3 PRRC2B ZNF703 NCOR1 TLE3 EP300 | 5.56e-06 | 187 | 215 | 11 | int:GATA3 |
| Interaction | NFIX interactions | ZNF536 POGZ BCOR CIC BAP1 GSE1 SAP130 EP400 BICRA NCOR1 TLE3 SMARCC2 | 6.24e-06 | 227 | 215 | 12 | int:NFIX |
| Interaction | KDM3A interactions | 7.21e-06 | 67 | 215 | 7 | int:KDM3A | |
| Interaction | PAX7 interactions | 7.44e-06 | 124 | 215 | 9 | int:PAX7 | |
| Interaction | AR interactions | GAK MYCBP2 PTBP1 BCL9 BCOR KLF4 CIC BAP1 GSE1 YAP1 GLI2 SAP130 FUBP3 PRRC2B EP400 SHC1 LARP1 HUWE1 MED13L NCOR1 TLE3 YLPM1 NCOA1 SMARCC2 PRKD1 RERE EP300 | 7.69e-06 | 992 | 215 | 27 | int:AR |
| Interaction | HNF4A interactions | POGZ BCOR CIC BAP1 GSE1 SAP130 EP400 BICRA YEATS2 NCOR1 NCOA1 SMARCC2 EP300 | 8.60e-06 | 275 | 215 | 13 | int:HNF4A |
| Interaction | KDM1A interactions | MYCBP2 POGZ BCOR TEX35 BIRC6 CIC BAP1 MRTFB GSE1 YAP1 AMOT BUB1B PHF21B EP400 BAG3 CAMSAP3 SHC1 DVL3 HUWE1 YEATS2 NCOR1 WDR6 TLE3 SMARCC2 RERE EP300 | 8.84e-06 | 941 | 215 | 26 | int:KDM1A |
| Interaction | OTUD4 interactions | DAZL ZCCHC2 CIC BAP1 YTHDF1 G3BP2 FUBP3 PRRC2B TSPYL6 UPF1 TLE3 DUSP10 | 9.25e-06 | 236 | 215 | 12 | int:OTUD4 |
| Interaction | PAX6 interactions | ZNF536 POGZ BCL9 BCOR CIC BAP1 GSE1 SAP130 PRRC2B EP400 BICRA NCOR1 TLE3 SMARCC2 EP300 | 9.75e-06 | 366 | 215 | 15 | int:PAX6 |
| Interaction | YWHAE interactions | DAB2IP MYCBP2 DISC1 SEC24A MAST2 CIC BAP1 RUSC2 HAVCR1 WWC2 YAP1 NHS SAP130 RAP1GAP PITRM1 BAG3 CAMSAP3 BRSK2 SHC1 LARP1 HUWE1 TAB3 C6orf132 LRCH3 ZNF106 PTPDC1 SIPA1L1 SMARCC2 PRKD1 MARK2 USP6NL | 1.10e-05 | 1256 | 215 | 31 | int:YWHAE |
| Interaction | TLX3 interactions | AOC1 POGZ BCL9 BCOR CIC GSE1 ZNF703 NOP53 POU2AF1 NCOR1 TLE3 RERE EP300 | 1.57e-05 | 291 | 215 | 13 | int:TLX3 |
| Interaction | ASF1A interactions | ZNF536 GATAD2A POGZ BCOR GSE1 SAP130 EP400 BICRA YEATS2 NCOR1 SMARCC2 EP300 | 1.58e-05 | 249 | 215 | 12 | int:ASF1A |
| Interaction | MEX3A interactions | IRAK2 DAZL FUBP3 PRRC2B RAP1GAP DVL3 LARP1 HUWE1 YEATS2 ARHGEF10 WDR6 TLN1 EIF4G1 ANKRD11 EP300 | 1.72e-05 | 384 | 215 | 15 | int:MEX3A |
| Interaction | VASP interactions | XIRP1 SEC24A YAP1 AMOT BUB1B NHS PITRM1 BAG3 C6orf132 C1orf198 ARHGEF10 SIPA1L1 FYB1 | 1.75e-05 | 294 | 215 | 13 | int:VASP |
| Interaction | TEAD1 interactions | 2.01e-05 | 176 | 215 | 10 | int:TEAD1 | |
| Interaction | PHF21A interactions | ZNF536 MYCBP2 BCOR BIRC6 CIC BAP1 MRTFB GSE1 AMOT BUB1B DVL3 HUWE1 YEATS2 WDR6 | 2.03e-05 | 343 | 215 | 14 | int:PHF21A |
| Interaction | FHL2 interactions | AMER1 MBNL1 POGZ BAP1 MRTFB AMOT SAP130 EP400 PLEKHG2 YEATS2 NCOR1 ZNF106 SIX5 DUSP10 EP300 | 2.46e-05 | 396 | 215 | 15 | int:FHL2 |
| Interaction | DAZL interactions | 2.62e-05 | 145 | 215 | 9 | int:DAZL | |
| Interaction | PPP2R1A interactions | MYCBP2 ECSIT CIC BAP1 NOD2 YAP1 GLI2 BUB1B SERTAD1 EP400 LARP1 VTA1 PPFIA3 PTPDC1 EIF4G1 DUSP10 MARK2 CCDC9 EP300 HR | 3.17e-05 | 665 | 215 | 20 | int:PPP2R1A |
| Interaction | YWHAB interactions | DAB2IP MYCBP2 AXL SEC24A MAST2 CIC BAP1 RUSC2 WWC2 YAP1 AMOT NHS SAP130 RAP1GAP BAG3 CAMSAP3 LARP1 C6orf132 ZNF106 PTPDC1 SIPA1L1 EIF4G1 MTNR1B MARK2 MAPK8 USP6NL | 3.20e-05 | 1014 | 215 | 26 | int:YWHAB |
| Interaction | CTBP1 interactions | GATAD2A BCOR KLF4 CIC PLCB1 NOS1 PRRC2B EP400 PCLO BAG3 DVL3 YEATS2 NCOR1 CCDC9 EP300 | 3.27e-05 | 406 | 215 | 15 | int:CTBP1 |
| Interaction | SP1 interactions | GAK POGZ BCOR KLF4 BAP1 NFKB2 SAP130 PITRM1 SHC1 NCOR1 TLN1 SMARCC2 MAPK8 EP300 | 4.01e-05 | 365 | 215 | 14 | int:SP1 |
| Interaction | EYA2 interactions | 4.72e-05 | 121 | 215 | 8 | int:EYA2 | |
| Interaction | ETS1 interactions | 4.72e-05 | 121 | 215 | 8 | int:ETS1 | |
| Interaction | SOX6 interactions | 4.90e-05 | 157 | 215 | 9 | int:SOX6 | |
| Interaction | FOXL1 interactions | 5.05e-05 | 196 | 215 | 10 | int:FOXL1 | |
| Interaction | NUP35 interactions | SEC24A MBNL1 BCL9 BCOR CIC YTHDF1 GSE1 SAP130 FUBP3 PRRC2B YEATS2 NCOR1 TLE3 YLPM1 EP300 | 5.36e-05 | 424 | 215 | 15 | int:NUP35 |
| Interaction | KLF16 interactions | RRP1B POGZ BCOR BAP1 YTHDF1 YAP1 G3BP2 SAP130 PRRC2B EP400 NOP53 LARP1 HUWE1 EIF4G1 EP300 | 5.51e-05 | 425 | 215 | 15 | int:KLF16 |
| Interaction | RNF43 interactions | SEC24A PTBP1 AMOT NHS FUBP3 PRRC2B BAG3 DVL3 LARP1 YBX3 TAB3 C6orf132 WDR6 USP6NL VPS13B | 5.80e-05 | 427 | 215 | 15 | int:RNF43 |
| Interaction | CEBPA interactions | GATAD2A RRP1B MYCBP2 MBNL1 POGZ PTBP1 BCL9 BCOR CIC GSE1 G3BP2 SAP130 FUBP3 PRRC2B EP400 BICRA LARP1 UPF1 MED13L YEATS2 NCOR1 ERGIC3 TLE3 TLN1 NCOA1 SMARCC2 BICRAL MAPK8 EP300 | 6.22e-05 | 1245 | 215 | 29 | int:CEBPA |
| Interaction | RUNX2 interactions | 6.30e-05 | 126 | 215 | 8 | int:RUNX2 | |
| Interaction | CELF1 interactions | MBNL1 DAZL PTBP1 YTHDF1 G3BP2 FUBP3 PRRC2B ZNF703 CAMSAP3 YBX3 UPF1 YLPM1 | 6.56e-05 | 288 | 215 | 12 | int:CELF1 |
| Interaction | RNF41 interactions | 6.87e-05 | 164 | 215 | 9 | int:RNF41 | |
| Interaction | TPX2 interactions | CIC CCDC85A YAP1 BUB1B SAP130 SFSWAP LRCH3 YLPM1 MARK2 EP300 | 7.06e-05 | 204 | 215 | 10 | int:TPX2 |
| Interaction | ZBTB7A interactions | 8.29e-05 | 131 | 215 | 8 | int:ZBTB7A | |
| Interaction | APEX1 interactions | HBS1L ZNF536 ZBTB48 RRP1B LRRC37A3 POGZ ECSIT PLXNB2 BAP1 GSE1 YAP1 PLCB1 RAP1GAP EP400 NOP53 SLC4A2 PTPDC1 C1orf198 SLC2A4RG ERGIC3 CSNK1G2 TLE3 TLN1 EIF4G1 ANKRD11 SMARCC2 MARK2 KIF13A EP300 | 8.94e-05 | 1271 | 215 | 29 | int:APEX1 |
| Interaction | PRPS2 interactions | HBS1L GATAD2A POGZ BAP1 BAG3 CAMSAP3 ADNP2 HUWE1 YEATS2 PRKD1 SNAPC4 | 9.07e-05 | 253 | 215 | 11 | int:PRPS2 |
| Interaction | HSP90AB1 interactions | EPHB6 MYCBP2 AXL SIRPA CIC BAP1 NOD2 YAP1 TRIM8 MVP TET3 ZNF541 BAG3 SHC1 UPF1 LRRK1 HUWE1 C6orf132 WDR6 CSNK1G2 TLN1 EIF4G1 SMARCC2 MARK2 | 9.71e-05 | 960 | 215 | 24 | int:HSP90AB1 |
| Interaction | FAM90A26 interactions | 1.13e-04 | 2 | 215 | 2 | int:FAM90A26 | |
| Interaction | GOLGA2 interactions | ZNF536 DISC1 MBNL1 BCOR TEX35 CIC RUSC2 GSE1 TSGA10IP MVP SAP130 WHRN BICRA FAM90A1 NCOR1 TLE3 ANKRD11 EP300 VPS13B INPP5J | 1.21e-04 | 733 | 215 | 20 | int:GOLGA2 |
| Interaction | ATXN1 interactions | ZXDC STAM2 GATAD2A MBNL1 POGZ BCOR CIC GSE1 SAP130 FUBP3 PRRC2B BAG3 LARP1 UPF1 HUWE1 BEND2 SLC4A2 NCOR1 TLE3 VSTM2L EIF4G1 HSFX1 SMARCC2 SIX5 BICRAL | 1.26e-04 | 1039 | 215 | 25 | int:ATXN1 |
| Interaction | NR1D1 interactions | 1.34e-04 | 25 | 215 | 4 | int:NR1D1 | |
| Interaction | FOXQ1 interactions | 1.38e-04 | 141 | 215 | 8 | int:FOXQ1 | |
| Interaction | BCL11B interactions | 1.39e-04 | 74 | 215 | 6 | int:BCL11B | |
| Interaction | YTHDF2 interactions | DAZL ZCCHC2 PLXNB2 CIC BAP1 YTHDF1 G3BP2 FUBP3 PRRC2B YBX3 UPF1 HUWE1 | 1.40e-04 | 312 | 215 | 12 | int:YTHDF2 |
| Interaction | TLX2 interactions | 1.45e-04 | 142 | 215 | 8 | int:TLX2 | |
| Interaction | HDAC4 interactions | HBS1L BCOR FMN1 GLI2 NFKB2 NAV3 PLCB1 PRRC2B CAMSAP3 SHC1 UPF1 HUWE1 NCOR1 CADPS WDR6 SIPA1L1 ANKRD11 MYOCD MARK2 INPP5J | 1.47e-04 | 744 | 215 | 20 | int:HDAC4 |
| Interaction | NCOA3 interactions | KLF4 MRTFB NCOR1 TLE3 ANKRD11 NCOA1 SMARCC2 MYOCD MAPK8 EP300 | 1.53e-04 | 224 | 215 | 10 | int:NCOA3 |
| Interaction | FBXO38 interactions | 1.68e-04 | 145 | 215 | 8 | int:FBXO38 | |
| Interaction | HNF1A interactions | 2.14e-04 | 80 | 215 | 6 | int:HNF1A | |
| Interaction | FMR1 interactions | MYCBP2 DAZL BCL9 YTHDF1 G3BP2 MVP FUBP3 PRRC2B BAG3 LARP1 UPF1 NCOR1 ZC2HC1A EIF4G1 SMARCC2 PRKD1 | 2.18e-04 | 536 | 215 | 16 | int:FMR1 |
| Interaction | SOX7 interactions | 2.45e-04 | 82 | 215 | 6 | int:SOX7 | |
| Interaction | RET interactions | STAM2 ZBTB48 AXL SEC24A PLXNB2 HPX SHC1 LRRK1 TLN1 MARK2 MAPK8 | 2.49e-04 | 284 | 215 | 11 | int:RET |
| Interaction | CSDE1 interactions | DAZL YTHDF1 YAP1 G3BP2 FUBP3 PRRC2B BAG3 UPF1 HUWE1 PRKD1 EP300 | 2.49e-04 | 284 | 215 | 11 | int:CSDE1 |
| Interaction | BTRC interactions | AMER1 MYCBP2 PTBP1 MAST2 GHR YTHDF1 YAP1 GLI2 G3BP2 NFKB2 BUB1B PRRC2B RAP1GAP LARP1 YBX3 UPF1 EIF4G1 PRKD1 PCDH8 EP300 | 2.52e-04 | 775 | 215 | 20 | int:BTRC |
| Interaction | SRPK2 interactions | HBS1L AMER1 RRP1B MYCBP2 PTBP1 MAST2 BAP1 GHR GSE1 PRRC2B SDK2 SFSWAP NOP53 BAG3 YBX3 FAM90A1 VSTM2L EIF4G1 EP300 | 2.59e-04 | 717 | 215 | 19 | int:SRPK2 |
| Interaction | MEN1 interactions | GATAD2A RRP1B POGZ YTHDF1 MRTFB GSE1 YAP1 G3BP2 NFKB2 MVP SAP130 FUBP3 EP400 NOP53 LARP1 YBX3 UPF1 NCOR1 TLE3 YLPM1 EIF4G1 SMARCC2 RERE KAT6B | 2.74e-04 | 1029 | 215 | 24 | int:MEN1 |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 RP1L1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A8 FAM90A16 FAM90A10 | 4.02e-10 | 154 | 229 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 ARHGEF10 RP1L1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A8 FAM90A16 FAM90A10 | 2.84e-09 | 234 | 229 | 12 | chr8p23 |
| Cytoband | 3q27 | 2.60e-04 | 25 | 229 | 3 | 3q27 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | AXL CIC SSC5D PROSER3 ZNF541 SERTAD1 NOP53 ZNF570 BICRA EID2B PLEKHG2 PPFIA3 ITPKC HSPB6 SIX5 CCDC9 | 3.57e-04 | 1192 | 229 | 16 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 4.75e-04 | 128 | 229 | 5 | chr3q27 | |
| Cytoband | Xp22.13 | 6.80e-04 | 8 | 229 | 2 | Xp22.13 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.24e-06 | 53 | 131 | 6 | 532 | |
| GeneFamily | PDZ domain containing | 1.50e-05 | 152 | 131 | 8 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.66e-04 | 160 | 131 | 7 | 555 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.35e-04 | 17 | 131 | 3 | 486 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.53e-04 | 181 | 131 | 7 | 694 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 5.14e-04 | 5 | 131 | 2 | 747 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.21e-03 | 163 | 131 | 6 | 590 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.31e-03 | 30 | 131 | 3 | 959 | |
| GeneFamily | Plexins | 1.81e-03 | 9 | 131 | 2 | 683 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZXDC ZNF536 ZBTB48 KLF4 BNC1 GLI2 ZNF398 ZNF541 ZFAT ZNF570 ADNP2 ZNF106 OSR1 | 2.15e-03 | 718 | 131 | 13 | 28 |
| GeneFamily | C1-set domain containing | 3.47e-03 | 42 | 131 | 3 | 591 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 5.14e-03 | 15 | 131 | 2 | 82 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 5.85e-03 | 16 | 131 | 2 | 66 | |
| Coexpression | PEREZ_TP53_TARGETS | DAB2IP ZXDC GAK ZBTB48 KIF26A MBNL1 BCOR BAP1 GHR LRRC37A GSE1 TRIM8 ZNF398 MICAL3 ABCD1 PRRC2B WHRN CRYBG2 ZNF570 CAPN3 DVL3 NLRP1 C6orf132 VCAN USP6NL VPS13B JPH3 HR | 8.03e-07 | 1201 | 217 | 28 | M4391 |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_UP | MAST2 MRTFB NFKB2 ZNF703 NOP53 POU2AF1 C6orf132 ERGIC3 RERE MAPK8 KIF13A | 9.61e-07 | 200 | 217 | 11 | M3423 |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | FILIP1 LRRC37A2 BCL9 TSC22D1 PRRC2B TCF7 ADNP2 MLLT10 MED13L LRRC8D | 5.38e-06 | 194 | 217 | 10 | M3321 |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 9.66e-06 | 164 | 217 | 9 | M5653 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 2.03e-05 | 180 | 217 | 9 | M8239 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP | POGZ BCOR GSE1 HPX ZNF398 ZNF703 CAMSAP3 HEXD SLC1A4 TLE3 SMARCC2 KAT6B INPP5J | 2.15e-05 | 385 | 217 | 13 | M2840 |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN | BCOR NOD2 TSC22D1 GSE1 SLC1A4 CSF2RB ARHGEF10 C11orf21 DUSP10 | 3.52e-05 | 193 | 217 | 9 | M4723 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | DAB2IP AMER1 RRP1B MYCBP2 MBNL1 PTBP1 LIME1 SPAAR YAP1 G3BP2 BUB1B PLCB1 BCAR3 ZFAT CAPN3 SHC1 LRRC8D CSNK1G2 SIPA1L1 USP6NL | 3.73e-05 | 865 | 217 | 20 | M2417 |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 4.10e-05 | 152 | 217 | 8 | M2938 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | RRP1B POGZ GSE1 BUB1B NAV3 BCAR3 MED13L BICRAL KAT6B USP6NL VPS13B | 4.45e-05 | 300 | 217 | 11 | M8702 |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP | 4.47e-05 | 199 | 217 | 9 | M9964 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D | DAB2IP AMER1 RRP1B MYCBP2 MBNL1 PTBP1 LIME1 SPAAR YAP1 G3BP2 BUB1B PLCB1 BCAR3 ZFAT CAPN3 SHC1 LRRC8D CSNK1G2 SIPA1L1 USP6NL | 5.37e-05 | 888 | 217 | 20 | MM1315 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | LRRC37A3 YAP1 FMN1 MED13L SIPA1L1 NCOA1 PRKD1 RERE KIF13A VPS13B | 5.32e-08 | 198 | 218 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.13e-07 | 183 | 218 | 9 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-07 | 193 | 218 | 9 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-07 | 193 | 218 | 9 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.33e-07 | 195 | 218 | 9 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 195 | 218 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-07 | 195 | 218 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.06e-07 | 198 | 218 | 9 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-07 | 200 | 218 | 9 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.80e-06 | 117 | 218 | 7 | 0602bbad908cb28c5093b74d717da5f2af577943 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.13e-06 | 120 | 218 | 7 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-06 | 176 | 218 | 8 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.81e-06 | 178 | 218 | 8 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 178 | 218 | 8 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.05e-06 | 187 | 218 | 8 | 9325cadd5f2c667d526696899e7aa36a98226d4b | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.21e-06 | 188 | 218 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-06 | 188 | 218 | 8 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.38e-06 | 189 | 218 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.11e-06 | 193 | 218 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-06 | 193 | 218 | 8 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.51e-06 | 195 | 218 | 8 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 196 | 218 | 8 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 196 | 218 | 8 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 5.72e-06 | 196 | 218 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.72e-06 | 196 | 218 | 8 | 9d7b631f24a19a7dc7a28f28525d4019fc8fcf8a | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.72e-06 | 196 | 218 | 8 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-06 | 197 | 218 | 8 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.94e-06 | 197 | 218 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.94e-06 | 197 | 218 | 8 | 5a63c2b824c7d0dbbc706e408459c9b9fe65daaa | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.17e-06 | 198 | 218 | 8 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.64e-06 | 200 | 218 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.15e-05 | 155 | 218 | 7 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 160 | 218 | 7 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 160 | 218 | 7 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 162 | 218 | 7 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 162 | 218 | 7 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 162 | 218 | 7 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 168 | 218 | 7 | 17fb9426eeea407b26fb895b8397faca95b7552d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 168 | 218 | 7 | 74d6dbf9295933acdee785af9b73a94377d15412 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 168 | 218 | 7 | a61b39884851384cffd430079040546d125b2b40 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 1.94e-05 | 168 | 218 | 7 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 172 | 218 | 7 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 173 | 218 | 7 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 173 | 218 | 7 | de124fb7ded04664d4184bf12f1f201c0784f07c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-05 | 174 | 218 | 7 | a79ebb01a5849c314e02594a9c95009dbb03cb8c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-05 | 174 | 218 | 7 | 42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.53e-05 | 175 | 218 | 7 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.53e-05 | 175 | 218 | 7 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.53e-05 | 175 | 218 | 7 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 178 | 218 | 7 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.82e-05 | 178 | 218 | 7 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-05 | 179 | 218 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 180 | 218 | 7 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.13e-05 | 181 | 218 | 7 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | IIH-plasma|IIH / Condition, Cell_class and T cell subcluster | 3.13e-05 | 181 | 218 | 7 | 13d1f31bcbac21aea91de74f51eed549ec61003e | |
| ToppCell | IIH-plasma-|IIH / Condition, Cell_class and T cell subcluster | 3.13e-05 | 181 | 218 | 7 | 140ac43dc6b89396872f908c14c89278f6d982b2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-05 | 183 | 218 | 7 | 8ace19c38b89556d2504258a63aa5a2b14f5cd36 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 3.36e-05 | 183 | 218 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-05 | 183 | 218 | 7 | dd15e1463a0d57d14800de0df0645c81c56926ae | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Lymphocytic-lymphocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 183 | 218 | 7 | a305667cfdae50e64e1890f10f71b407ae617b80 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.48e-05 | 184 | 218 | 7 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 184 | 218 | 7 | 842473fa415575441b595073a994b6d621169776 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-05 | 184 | 218 | 7 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 184 | 218 | 7 | 590fb32bb1f348ea5fa2aece30ebe1e212512991 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.60e-05 | 185 | 218 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.73e-05 | 186 | 218 | 7 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 218 | 7 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.73e-05 | 186 | 218 | 7 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.73e-05 | 186 | 218 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.86e-05 | 187 | 218 | 7 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 3.86e-05 | 187 | 218 | 7 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.13e-05 | 189 | 218 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 189 | 218 | 7 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.13e-05 | 189 | 218 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 189 | 218 | 7 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-05 | 190 | 218 | 7 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-05 | 190 | 218 | 7 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 4.27e-05 | 190 | 218 | 7 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 190 | 218 | 7 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.27e-05 | 190 | 218 | 7 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 191 | 218 | 7 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 4.41e-05 | 191 | 218 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 192 | 218 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 194 | 218 | 7 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 195 | 218 | 7 | 5dc874641ad9537e4c1369825c1fb0a59f12a83d | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 5.03e-05 | 195 | 218 | 7 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.03e-05 | 195 | 218 | 7 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | T_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.36e-05 | 197 | 218 | 7 | ec9398ae3577f61d6b1e6aba50ef4261aaaa7610 | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.36e-05 | 197 | 218 | 7 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 197 | 218 | 7 | 02e70768a917c5f097bc653e9e965a1000289d2e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 197 | 218 | 7 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 197 | 218 | 7 | aafe279b14cdcb786bc45524bc3c26261128ee48 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 197 | 218 | 7 | 8b3bf5b45e49bf1c60e4d2703b470bb890385f67 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-05 | 197 | 218 | 7 | fb14da600f563273059a4683a5079af81aca0886 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.36e-05 | 197 | 218 | 7 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.54e-05 | 198 | 218 | 7 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 5.54e-05 | 198 | 218 | 7 | 30ada3de865b6fb2b14196a1cbfd4740c6a57ce3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.54e-05 | 198 | 218 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.54e-05 | 198 | 218 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; HL60; HT_HG-U133A | RIBC2 AXL AZGP1 PLCB1 CRYBG2 PCLO ARHGEF10 SIPA1L1 VCAN RERE MADCAM1 | 1.76e-06 | 188 | 214 | 11 | 3046_UP |
| Drug | pyrachlostrobin | AXL MFRP KLF4 PLXNB2 GHR SSC5D YAP1 AMOT GLI2 NFKB2 MVP SERTAD1 TCF7 BAG3 SHC1 LRRK1 PLEKHG2 SLC4A2 ARHGEF10 TLN1 CSRP1 OSR1 FYB1 | 2.62e-06 | 811 | 214 | 23 | ctd:C513428 |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; HL60; HT_HG-U133A | RIBC2 DISC1 NOS1 PRRC2B NLRP1 ITPKC TLE3 NCOA1 SMARCC2 MAPK8 MUC1 | 2.65e-06 | 196 | 214 | 11 | 1311_UP |
| Drug | Betamethasone [378-44-9]; Down 200; 10.2uM; PC3; HT_HG-U133A | RIBC2 PLXND1 NFKB2 KCNN1 NOS1 LRRK1 ARHGEF10 VCAN HSPB6 SNAPC4 FYB1 | 2.65e-06 | 196 | 214 | 11 | 6728_DN |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | TRPC4AP PLXND1 BNC1 IL27RA PPFIA3 SLC1A4 SLC4A2 VCAN YLPM1 SMARCC2 GREM1 | 2.78e-06 | 197 | 214 | 11 | 6359_DN |
| Drug | Cefotetan [69712-56-7]; Down 200; 7uM; HL60; HT_HG-U133A | HBS1L PLXND1 CIC ABCD1 EP400 BICRA CAPN3 NLRP1 LRRK1 SLC4A2 SIPA1L1 | 3.07e-06 | 199 | 214 | 11 | 1319_DN |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | STAM2 AZGP1 BCAR3 CAPN3 NLRP1 THPO HSPB6 YLPM1 NCOA1 MAPK8 JPH3 | 3.07e-06 | 199 | 214 | 11 | 3017_DN |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; HL60; HG-U133A | TRPC4AP MAST2 BICRA NLRP1 MED13L SLC4A2 ZC2HC1A ARHGEF10 TLE3 TLN1 FYB1 | 3.07e-06 | 199 | 214 | 11 | 2012_UP |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.27e-05 | 189 | 214 | 10 | 1206_DN | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | AXL KLF4 PLXNB2 SSC5D NFKB2 BAG3 SHC1 LRRK1 PLEKHG2 SLC4A2 CADPS TLN1 CSRP1 PRKD1 | 1.28e-05 | 373 | 214 | 14 | ctd:C540355 |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; HL60; HT_HG-U133A | TRPC4AP SEC24A MAST2 ABCD1 TCF7 YLPM1 C11orf21 NCOA1 KAT6B FYB1 | 1.60e-05 | 194 | 214 | 10 | 1264_DN |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A | 1.74e-05 | 196 | 214 | 10 | 2089_DN | |
| Drug | Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A | ABCD1 PRRC2B TCF7 SLC4A2 NCOR1 FICD TLN1 C11orf21 SMARCC2 KAT6B | 1.74e-05 | 196 | 214 | 10 | 1301_DN |
| Drug | Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; HL60; HG-U133A | 1.82e-05 | 197 | 214 | 10 | 1789_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; MCF7; HT_HG-U133A | 1.82e-05 | 197 | 214 | 10 | 2244_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.82e-05 | 197 | 214 | 10 | 2766_UP | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 1.90e-05 | 198 | 214 | 10 | 2724_DN | |
| Drug | Brinzolamide [138890-62-7]; Down 200; 10.4uM; HL60; HG-U133A | POGZ SIRPA PTBP1 BAP1 RAP1GAP MED13L YLPM1 NCOA1 DUSP10 KAT6B | 1.90e-05 | 198 | 214 | 10 | 1615_DN |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A | 1.99e-05 | 199 | 214 | 10 | 6355_DN | |
| Drug | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | DAB2IP IRAK2 PLXND1 ECSIT CCDC85A RUSC2 GHR AMOT TRIM8 PLCB1 BCAR3 SFSWAP PLEKHG2 LRRC8D SLC1A4 SLC6A9 NCOR1 TLE3 VCAN OSR1 GREM1 | 2.64e-05 | 807 | 214 | 21 | ctd:C548651 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.14e-05 | 174 | 214 | 9 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.13e-05 | 183 | 214 | 9 | 4770_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 6.67e-05 | 185 | 214 | 9 | 5585_DN | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 7.55e-05 | 188 | 214 | 9 | 1176_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 8.18e-05 | 190 | 214 | 9 | 2619_DN | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; HL60; HG-U133A | 8.52e-05 | 191 | 214 | 9 | 2038_DN | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 8.52e-05 | 191 | 214 | 9 | 521_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.23e-05 | 193 | 214 | 9 | 1644_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 9.23e-05 | 193 | 214 | 9 | 6646_DN | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 4411_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; HL60; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 1267_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 9.60e-05 | 194 | 214 | 9 | 3774_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 5820_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 5329_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 9.98e-05 | 195 | 214 | 9 | 1927_UP | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 5591_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.98e-05 | 195 | 214 | 9 | 7327_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 2907_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 1182_DN | |
| Drug | radicicol; Up 200; 0.1uM; SKMEL5; HG-U133A | 1.04e-04 | 196 | 214 | 9 | 493_UP | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; PC3; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 4212_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; HL60; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 2560_UP | |
| Drug | SC-58125; Down 200; 10uM; SKMEL5; HG-U133A | 1.04e-04 | 196 | 214 | 9 | 507_DN | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.04e-04 | 196 | 214 | 9 | 5341_UP | |
| Drug | Pp55 | 1.05e-04 | 50 | 214 | 5 | CID000132900 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 5819_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 4774_DN | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 5541_UP | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 6203_UP | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 7132_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 6198_UP | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 2689_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 1855_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 1697_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.08e-04 | 197 | 214 | 9 | 2070_DN | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 3537_DN | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; HL60; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 2577_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 3402_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 4185_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 200uM; SKMEL5; HG-U133A | AOC1 MC3R NLRP1 PPFIA3 SLC2A4RG ARHGEF10 CSNK1G2 TLE3 SMARCC2 | 1.12e-04 | 198 | 214 | 9 | 502_DN |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 5414_DN | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 3081_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 7006_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; PC3; HG-U133A | 1.12e-04 | 198 | 214 | 9 | 457_UP | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 5864_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 5829_DN | |
| Drug | Chlorogenic acid [327-97-9]; Down 200; 11.2uM; HL60; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 1346_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 1.12e-04 | 198 | 214 | 9 | 4194_DN | |
| Drug | AH6809; Up 200; 1uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 214 | 9 | 7075_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.16e-04 | 199 | 214 | 9 | 7366_UP | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.16e-04 | 199 | 214 | 9 | 6214_DN | |
| Drug | polyproline | IRAK2 SIRPA RUSC2 YAP1 KISS1 WHRN MLLT10 SLC4A2 SLC2A4RG USP6NL JPH3 | 1.17e-04 | 295 | 214 | 11 | CID000439587 |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.21e-04 | 200 | 214 | 9 | 2648_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; HL60; HT_HG-U133A | 1.21e-04 | 200 | 214 | 9 | 3078_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; HL60; HG-U133A | 1.21e-04 | 200 | 214 | 9 | 2027_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A | 1.21e-04 | 200 | 214 | 9 | 1376_DN | |
| Disease | Malignant neoplasm of breast | XIRP1 RIBC2 LRRC37A2 CIC BAP1 ADRA1A LRRC37A YAP1 G3BP2 PLCB1 NHS BCAR3 ZNF541 RAP1GAP FRMPD1 DVL3 NCOR1 TLE3 SIPA1L1 NCOA1 KAT6B PCDH8 EP300 VPS13B | 9.52e-07 | 1074 | 212 | 24 | C0006142 |
| Disease | Embryonal Rhabdomyosarcoma | 1.99e-05 | 8 | 212 | 3 | C0206656 | |
| Disease | obesity (implicated_via_orthology) | 2.74e-05 | 215 | 212 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | level of tyrosine-protein phosphatase non-receptor type substrate 1 in blood serum | 5.14e-05 | 2 | 212 | 2 | OBA_2040362 | |
| Disease | vital capacity | FILIP1 AOC1 MBNL1 TENM2 GHR PLCB1 MICAL3 TSGA10IP ZFAT PCLO FRMPD1 VTA1 MLLT10 NCOR1 ZNF106 PTPDC1 SLC2A4RG NCOA1 DMRTA1 DUSP10 SNAPC4 MUC1 | 8.95e-05 | 1236 | 212 | 22 | EFO_0004312 |
| Disease | colorectal cancer (is_implicated_in) | 2.48e-04 | 121 | 212 | 6 | DOID:9256 (is_implicated_in) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 2.76e-04 | 18 | 212 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Meningioma | 3.25e-04 | 19 | 212 | 3 | C0025286 | |
| Disease | lymphocyte percentage of leukocytes | AOC1 MBNL1 SIRPB1 PTBP1 PLCB1 IL27RA SERTAD1 MFSD2B POU2AF1 LRRK1 ZC2HC1A DMRTA1 RERE SNAPC4 | 3.50e-04 | 665 | 212 | 14 | EFO_0007993 |
| Disease | Autism Spectrum Disorders | 3.76e-04 | 85 | 212 | 5 | C1510586 | |
| Disease | hemoglobin A1 measurement | HBS1L MBNL1 PLXND1 PTBP1 MAST2 PLCB1 ZFAT MFSD2B LARP1 RP1L1 MTNR1B DMRTA1 | 4.13e-04 | 520 | 212 | 12 | EFO_0007629 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.26e-04 | 49 | 212 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | C-reactive protein measurement | ZNF536 MBNL1 PTBP1 ZCCHC2 LIME1 MICAL3 RAP1GAP MFSD2B MLLT10 SLC6A9 YEATS2 NCOR1 ZNF106 CSNK1G2 RP1L1 CSRP1 SMARCC2 RERE SNAPC4 FYB1 | 4.69e-04 | 1206 | 212 | 20 | EFO_0004458 |
| Disease | Neurodevelopmental Disorders | 5.68e-04 | 93 | 212 | 5 | C1535926 | |
| Disease | Unipolar Depression | 6.02e-04 | 259 | 212 | 8 | C0041696 | |
| Disease | Bipolar Disorder | DISC1 ZCCHC2 BCL9 NOD2 ADRA1A PLCB1 WHRN PCLO ARHGEF10 CSRP1 RIMS1 | 7.19e-04 | 477 | 212 | 11 | C0005586 |
| Disease | myotonic dystrophy type 1 (implicated_via_orthology) | 7.56e-04 | 6 | 212 | 2 | DOID:11722 (implicated_via_orthology) | |
| Disease | neurotic disorder | 8.27e-04 | 101 | 212 | 5 | EFO_0004257 | |
| Disease | serum gamma-glutamyl transferase measurement | AXL PTBP1 TEX35 TENM2 WWC2 GSE1 MICAL3 ABCD1 BICRA TMPRSS11E NLRP1 ZNRF2 TLN1 RP1L1 USP6NL JPH3 | 9.95e-04 | 914 | 212 | 16 | EFO_0004532 |
| Disease | reaction time measurement | GATAD2A LRRC37A2 TENM2 CCDC85A ADRA1A ZFAT MFSD2B NLRP1 YBX3 MED13L NCOA1 RIMS1 RERE | 1.01e-03 | 658 | 212 | 13 | EFO_0008393 |
| Disease | glomerular filtration rate, response to platinum based chemotherapy | 1.05e-03 | 28 | 212 | 3 | EFO_0004647, EFO_0005208 | |
| Disease | myeloid white cell count | HBS1L MBNL1 ZCCHC2 BCL9 MAST2 CIC HAVCR1 PLCB1 ZNF398 BCAR3 SERTAD1 VTA1 LRRK1 TLE3 DMRTA1 RERE | 1.29e-03 | 937 | 212 | 16 | EFO_0007988 |
| Disease | asymmetrical dimethylarginine measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0006522 | |
| Disease | obsessive-compulsive symptom measurement | 1.42e-03 | 31 | 212 | 3 | EFO_0007802 | |
| Disease | schizophrenia (implicated_via_orthology) | 1.47e-03 | 68 | 212 | 4 | DOID:5419 (implicated_via_orthology) | |
| Disease | platelet crit | HBS1L GATAD2A KIF26A SIRPB1 SIRPA HAVCR1 GSE1 NAV3 PLCB1 MFSD2B THPO TLN1 YLPM1 DMRTA1 RERE FYB1 | 1.51e-03 | 952 | 212 | 16 | EFO_0007985 |
| Disease | Intellectual Disability | DISC1 POGZ CIC TRIM8 TET3 PITRM1 BRSK2 MED13L SLC1A4 SMARCC2 | 1.56e-03 | 447 | 212 | 10 | C3714756 |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 1.79e-03 | 9 | 212 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 1.79e-03 | 9 | 212 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | signal-regulatory protein beta-1 measurement | 1.79e-03 | 9 | 212 | 2 | EFO_0802069 | |
| Disease | Colorectal Carcinoma | EPHB6 GSE1 YAP1 BUB1B NPAP1 ERGIC3 EIF4G1 DMRTA1 PRKD1 GREM1 EP300 JPH3 HR | 1.80e-03 | 702 | 212 | 13 | C0009402 |
| Disease | forced expiratory volume | FILIP1 BCL9 PLXNB2 SSC5D MICAL3 TSGA10IP PRRC2B ZFAT LARP1 VTA1 NCOR1 PTPDC1 SLC2A4RG MUC1 | 1.80e-03 | 789 | 212 | 14 | EFO_0004314 |
| Disease | urate measurement, bone density | DAB2IP TENM2 GSE1 YAP1 GLI2 PLCB1 PRRC2B CSF2RB ANKRD11 MAPK8 KAT6B JPH3 | 1.84e-03 | 619 | 212 | 12 | EFO_0003923, EFO_0004531 |
| Disease | cutaneous melanoma | 1.85e-03 | 121 | 212 | 5 | EFO_0000389 | |
| Disease | balding measurement | HBS1L ZNF536 MYCBP2 MBNL1 CIC GSE1 FMN1 GLI2 BCAR3 CRYBG2 BICRA LRRK1 PRKD1 RERE | 1.87e-03 | 792 | 212 | 14 | EFO_0007825 |
| Disease | Major Depressive Disorder | 1.96e-03 | 243 | 212 | 7 | C1269683 | |
| Disease | lymphocyte count | HBS1L AOC1 MBNL1 PLXND1 PLXNB2 BNC1 HAVCR1 NFKB2 PLCB1 MICAL3 ABCD1 IL27RA ZFAT MFSD2B MED13L NCOR1 ZC2HC1A TLN1 ANKRD11 DMRTA1 RERE | 2.09e-03 | 1464 | 212 | 21 | EFO_0004587 |
| Disease | puberty onset measurement | 2.13e-03 | 125 | 212 | 5 | EFO_0005677 | |
| Disease | white matter microstructure measurement | 2.15e-03 | 390 | 212 | 9 | EFO_0005674 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 2.23e-03 | 10 | 212 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | glucagon-like peptide-1 measurement | 2.23e-03 | 10 | 212 | 2 | EFO_0008465 | |
| Disease | disposition index measurement, glucose homeostasis measurement | 2.23e-03 | 10 | 212 | 2 | EFO_0006832, EFO_0006896 | |
| Disease | neutrophil count | HBS1L MYCBP2 MBNL1 POGZ SIRPB1 ZCCHC2 BCL9 MAST2 CIC HAVCR1 PLCB1 ZNF398 SERTAD1 VTA1 PLEKHG2 RP1L1 ANKRD11 NCOA1 RERE CCDC9 | 2.41e-03 | 1382 | 212 | 20 | EFO_0004833 |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 2.61e-03 | 131 | 212 | 5 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 2.61e-03 | 131 | 212 | 5 | C4552091 | |
| Disease | Juvenile arthritis | 2.61e-03 | 131 | 212 | 5 | C3495559 | |
| Disease | irritable bowel syndrome | 2.61e-03 | 131 | 212 | 5 | EFO_0000555 | |
| Disease | Juvenile psoriatic arthritis | 2.61e-03 | 131 | 212 | 5 | C3714758 | |
| Disease | Umbilical hernia | 2.71e-03 | 11 | 212 | 2 | HP_0001537 | |
| Disease | mean corpuscular hemoglobin concentration | HBS1L GATAD2A AXL LRRC37A2 SIRPA PLCB1 ZFAT EP400 DVL3 LARP1 SLC4A2 SLC6A9 SLC2A4RG RP1L1 C11orf21 DMRTA1 VPS13B | 2.74e-03 | 1105 | 212 | 17 | EFO_0004528 |
| Disease | lactate measurement | 2.76e-03 | 39 | 212 | 3 | EFO_0007745 | |
| Disease | cortical thickness | ZNF536 GATAD2A MYCBP2 PLXND1 MAST2 TENM2 BNC1 NAV3 MICAL3 MLLT10 ZNF106 CADPS VCAN YLPM1 DMRTA1 RERE KIF13A | 2.94e-03 | 1113 | 212 | 17 | EFO_0004840 |
| Disease | Kidney Neoplasm | 2.97e-03 | 40 | 212 | 3 | C0022665 | |
| Disease | Juvenile-Onset Still Disease | 2.98e-03 | 135 | 212 | 5 | C0087031 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 3.19e-03 | 41 | 212 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 3.19e-03 | 41 | 212 | 3 | C0858252 | |
| Disease | bipolar disorder | ZCCHC2 TRIM8 WHRN BICRA PCLO HUWE1 TLE3 LAMP3 BICRAL PRKD1 RIMS1 | 3.21e-03 | 577 | 212 | 11 | MONDO_0004985 |
| Disease | Clear Cell Meningioma | 3.23e-03 | 12 | 212 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 3.23e-03 | 12 | 212 | 2 | C1334271 | |
| Disease | Benign Meningioma | 3.23e-03 | 12 | 212 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 3.23e-03 | 12 | 212 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 3.23e-03 | 12 | 212 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 3.23e-03 | 12 | 212 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 3.23e-03 | 12 | 212 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 3.23e-03 | 12 | 212 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 3.23e-03 | 12 | 212 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 3.23e-03 | 12 | 212 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 3.23e-03 | 12 | 212 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 3.23e-03 | 12 | 212 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 3.23e-03 | 12 | 212 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 3.23e-03 | 12 | 212 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 3.23e-03 | 12 | 212 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 3.23e-03 | 12 | 212 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 3.23e-03 | 12 | 212 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 3.23e-03 | 12 | 212 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 3.23e-03 | 12 | 212 | 2 | C1384408 | |
| Disease | Secretory meningioma | 3.23e-03 | 12 | 212 | 2 | C1384406 | |
| Disease | serum albumin measurement | HBS1L AOC1 GATAD2A MBNL1 WDR81 ZCCHC2 TEX35 MICAL3 ZFAT CAPN3 MLLT10 | 3.89e-03 | 592 | 212 | 11 | EFO_0004535 |
| Disease | cortical surface area measurement | FILIP1 ZNF536 MYCBP2 PLXND1 MAST2 PLXNB2 TENM2 TRIM8 NAV3 BRSK2 MED13L NCOR1 ZNF106 CADPS VCAN RP1L1 DMRTA1 PRKD1 RERE | 3.99e-03 | 1345 | 212 | 19 | EFO_0010736 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.04e-03 | 145 | 212 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of kidney | 4.16e-03 | 45 | 212 | 3 | C0740457 | |
| Disease | Malignant neoplasm of salivary gland | 4.16e-03 | 45 | 212 | 3 | C0220636 | |
| Disease | amyloid-beta measurement | 4.32e-03 | 355 | 212 | 8 | EFO_0005194 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.40e-03 | 148 | 212 | 5 | C0279702 | |
| Disease | Acute Promyelocytic Leukemia | 4.42e-03 | 46 | 212 | 3 | C0023487 | |
| Disease | cleft lip | 4.62e-03 | 284 | 212 | 7 | EFO_0003959 | |
| Disease | Salivary Gland Neoplasms | 4.70e-03 | 47 | 212 | 3 | C0036095 | |
| Disease | Mammary Carcinoma, Human | RIBC2 LRRC37A2 BAP1 LRRC37A YAP1 BCAR3 NCOR1 TLE3 NCOA1 EP300 | 4.90e-03 | 525 | 212 | 10 | C4704874 |
| Disease | Mammary Neoplasms, Human | RIBC2 LRRC37A2 BAP1 LRRC37A YAP1 BCAR3 NCOR1 TLE3 NCOA1 EP300 | 4.90e-03 | 525 | 212 | 10 | C1257931 |
| Disease | Schizophrenia | DISC1 MBNL1 SIRPB1 CMYA5 BCL9 ADRA1A PLCB1 NOS1 ADNP2 SLC6A9 CSF2RB MARK2 MAPK8 PCDH8 | 4.91e-03 | 883 | 212 | 14 | C0036341 |
| Disease | colorectal cancer, colorectal adenoma | 4.93e-03 | 152 | 212 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | mean fractional anisotropy measurement | 4.95e-03 | 95 | 212 | 4 | EFO_0008399 | |
| Disease | Mammary Neoplasms | RIBC2 LRRC37A2 BAP1 LRRC37A YAP1 BCAR3 NCOR1 TLE3 NCOA1 EP300 | 5.03e-03 | 527 | 212 | 10 | C1458155 |
| Disease | response to irinotecan | 5.07e-03 | 15 | 212 | 2 | EFO_0004829 | |
| Disease | total blood protein measurement | 5.41e-03 | 449 | 212 | 9 | EFO_0004536 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEQPHSKGPSVPFSI | 516 | O60566 | |
| RPHSEKGPQASPSAQ | 46 | Q8N944 | |
| SPQTSSPHPGLVAAQ | 2341 | Q09472 | |
| TGPPVQNAASLHTPL | 576 | Q96L91 | |
| QPQAPSHAAGQSALP | 1571 | Q96L91 | |
| PLPHQEATPRASKGA | 176 | P04920 | |
| AVAQAEVPASPATGP | 1021 | Q4VCS5 | |
| HPPESLAVVANAKPN | 726 | O15013 | |
| PPAAENKLHPASGAD | 1661 | Q6UB99 | |
| ASAVGPVHNSVPSNP | 1666 | Q9NR09 | |
| PVHNSVPSNPVAAPG | 1671 | Q9NR09 | |
| VAPLPFSTDIGHPQN | 2346 | P13611 | |
| GTLPHSKSPRQNSPV | 71 | O75815 | |
| VGPSTPSLDKNHQVP | 436 | P35348 | |
| APKDIPVPLSHSTNG | 996 | Q14687 | |
| PVDKGNPSSIHPFEN | 221 | Q01954 | |
| KVPGSTPALHSSPAQ | 36 | Q96SM3 | |
| AGSPAVAVPTHSQPS | 471 | Q92560 | |
| ASAHVQPKPAPEASS | 266 | Q5JTC6 | |
| IPHSEDIPNTATPGN | 676 | P19801 | |
| SDQDTLAPLPHPGAA | 516 | Q92997 | |
| QHVGQPPATPAKHSS | 596 | Q6W2J9 | |
| HAASPRGTEASPPQN | 331 | Q9P1Y5 | |
| TLASAGQIPFHAEPP | 526 | Q9NRI5 | |
| SPEKPGAFLAQSPHV | 416 | A6NDY2 | |
| IAPKPAAHLAAPANG | 266 | Q6IQ32 | |
| KTTAEPQHQSPPGIS | 611 | Q68DA7 | |
| APTPEEHAQGAVTKP | 521 | Q96DU7 | |
| SPEKPGAFLAQSPHV | 416 | A6NKC0 | |
| FLVTAQNPAHEPSPG | 341 | Q08AF8 | |
| HTPQKGPPIEDAIAS | 191 | Q9Y450 | |
| HPGQSVRSVNSPSVP | 1606 | Q8WYB5 | |
| GEAVAPAHVPAPSPQ | 721 | P33897 | |
| QLQAAPPSGASHSPL | 91 | Q9BY79 | |
| TAPAQAKAEPTAAPH | 481 | Q86YP4 | |
| RATGQSHKPVPPTQV | 621 | Q9ULU8 | |
| VHKQGPSPVSPNALD | 986 | Q5VWQ8 | |
| SPEKPGAFLAQSPHV | 416 | A8MXZ1 | |
| LTTVNGQSPPEHSAP | 136 | Q6PKG0 | |
| GQSPPEHSAPAKVVR | 141 | Q6PKG0 | |
| SKGSPDGSHPVVVAP | 251 | O43474 | |
| PEVTLPPSDKGQAQH | 696 | O60309 | |
| PVKTSALIPNGANPH | 476 | Q15139 | |
| ETNKGHASPLPPSAA | 621 | Q96II8 | |
| PASPKHQERGPSQAT | 1141 | Q7RTP6 | |
| KPSQAPAVEVAPAGA | 231 | Q9NZM5 | |
| ALPVAQVPTDPGHFS | 61 | O14558 | |
| DKTSPEPAPQQGSTH | 266 | Q13477 | |
| VTTPGHSTPVPDGKN | 756 | Q71F56 | |
| LQHNSPPPKERAATG | 141 | Q3KP22 | |
| PEVTLPPSDKGQAQH | 696 | A6NM11 | |
| PEVTLPPSDKGQAQH | 696 | A6NMS7 | |
| GAIPPPDKAQHNDSE | 31 | O60565 | |
| PGSSPARAHQPAFLQ | 141 | O43187 | |
| PPAASHTANPKVPEG | 1796 | Q38SD2 | |
| SPEKPGAFLAQSPHV | 416 | Q86YD7 | |
| PPSPAREGTDKANHV | 681 | O75145 | |
| PKIINTVPHSAAVPG | 1756 | Q5HYC2 | |
| PPHSPGLQVVVAKSE | 36 | Q92952 | |
| PEAQPNHSGFKETLP | 441 | Q9BVA6 | |
| DQTPKAVPQHLDASP | 381 | A9Z1Z3 | |
| PTAGHSNAPITAPAE | 376 | P78368 | |
| QSPAPPIIGVQHQAD | 346 | P49286 | |
| HDVTSAPDNKPAPGS | 116 | P15941 | |
| PALGSTAPPVHNVTS | 946 | P15941 | |
| TPPCPVAHGDQIVSQ | 121 | Q8NDZ0 | |
| AQAPSTPAKRSAHGP | 686 | Q8IWQ3 | |
| NPGSNSHPPVIATTV | 36 | Q9Y6W6 | |
| HEAAPSQLEGKLPSP | 276 | Q9H425 | |
| PGHRPTTNPNASKFA | 96 | P21291 | |
| SVPGLASAPDPHQQL | 71 | Q96D98 | |
| QAPGEAVLVPAGAPH | 1111 | O43593 | |
| SPEKPGAFLAQSPHV | 416 | A8MWA6 | |
| SPEKPGAFLAQSPHV | 416 | P0C7W9 | |
| KPIQGPTQTPQTDHA | 256 | Q9Y6V0 | |
| QSVLAPGHAVPPAVK | 1641 | O15031 | |
| HPNASTVGLVLPPAA | 186 | Q9Y4D7 | |
| PSPLGAAVINGSQHP | 376 | P45983 | |
| APVLVHPAPANGSLE | 606 | O95206 | |
| HPAPANGSLEVAVPG | 611 | O95206 | |
| AVVGTPPQAHTSLQP | 236 | Q9C000 | |
| RQPAVGSKPVHTALP | 11 | Q8IVL0 | |
| PGIVNPLDHTNVTAP | 256 | Q9Y282 | |
| AKVNGNPHSTPVSGP | 466 | Q96I24 | |
| PAFGQKPPLSTENSH | 196 | O15117 | |
| RPLEAQPSAPGHSVK | 601 | Q9ULH7 | |
| QPIPVASHAVGQPVS | 641 | Q9ULH7 | |
| KGATGPSQAVPPVEH | 256 | Q8WVB3 | |
| EKVPDPANSSSGQPH | 556 | Q6UWB1 | |
| LSAPHSRQIPAPQGA | 86 | Q15726 | |
| TGQKPVQPTHAPGTT | 181 | Q9UQV4 | |
| PPHAVNPARVGAAAV | 1381 | Q9ULI4 | |
| ATPGPVTVSPNAAHL | 216 | A6NFX1 | |
| DSALAGVPPPHPVQS | 1306 | P10070 | |
| GEPVSPSFANVHKDP | 501 | A2A3K4 | |
| SPEKPGAFLAQSPHV | 416 | P0DV74 | |
| PQQAASSFGPHRVVP | 261 | Q9H4K1 | |
| SPEKPGAFLAQSPHV | 416 | P0DV73 | |
| KADGTATAPPPRSNH | 706 | Q7Z6Z7 | |
| SPEKPGAFLAQSPHV | 416 | P0DV76 | |
| GPPSTPIAVHAAVKS | 226 | Q8IZQ8 | |
| SAQAPQAPGDNHVVP | 876 | Q14764 | |
| AVNGLPTVPSDHLPN | 26 | Q8TAX0 | |
| SHQPPAGKEQPLAVD | 136 | P29475 | |
| TRAPGAKQLTNHSPP | 436 | Q86UR5 | |
| SGAAPAPTAVVLPHQ | 41 | Q16633 | |
| SPEKPGAFLAQSPHV | 416 | A6NJQ4 | |
| SAGPSHVAAMNIPIP | 981 | Q92900 | |
| AQENHGLAVPTPSVP | 86 | Q5T0Z8 | |
| LHSEVGAGPAVPPQA | 886 | O14976 | |
| TASHINPQKDPTADP | 566 | Q711Q0 | |
| PGPPAASHTPEKQAS | 571 | P32927 | |
| FLVTAQNPAHEPSPG | 341 | Q0D2H9 | |
| PQQEKVVGSSPGHPA | 666 | Q6AI39 | |
| IGKPHPQSFQPAAAT | 891 | Q9BX69 | |
| PQPLPTEGAESTHQA | 456 | P10912 | |
| PAQDHQAPEAAPTGI | 446 | Q9Y3X0 | |
| VPPEGIKAEAPNHVT | 1221 | Q5SYB0 | |
| SSSGIPPHVKAPVSQ | 261 | Q9UN86 | |
| KSPPVLGSAAASPVH | 906 | O00512 | |
| PALGNEKEAHRSTPP | 2081 | Q8N3K9 | |
| SNKPDSILSPHPGEQ | 271 | Q5VZB9 | |
| IPASAHLPKNQDAPA | 296 | Q8N1P7 | |
| FSGHATPSQQPEPVV | 506 | Q96PX6 | |
| GSGVPQVKSHSQPEP | 291 | A0A1W2PPF3 | |
| VQSAAPARPGPAAHV | 66 | Q04637 | |
| PGVPVPAAAAAAAQK | 161 | Q9NR56 | |
| ASVHPNKASGLPPTE | 536 | Q7KZI7 | |
| APQRVPVASPSAHNI | 561 | Q7KZI7 | |
| EQGKTQPPSAPRLAH | 1701 | Q6P0Q8 | |
| IAALPPADGVAPQQH | 221 | P41968 | |
| KEGSTFPPVEQHPIQ | 561 | A6NN90 | |
| QGPNKHPVGTTVAPL | 406 | Q9NRM1 | |
| SVHEATPPSGNGPQK | 231 | Q92904 | |
| SPEKPGAFLAQSPHV | 416 | A6NIJ5 | |
| AAAAAQPPASHGPER | 156 | O95817 | |
| QQPLSAEGPHLSVPA | 706 | Q9NZM4 | |
| GPVPHPAQSKATEAG | 21 | P20807 | |
| SPEKPGAFLAQSPHV | 416 | A8MXJ8 | |
| PTVPPGNVHAEATNS | 791 | Q58EX2 | |
| KQDVLGPSTTPPAHS | 486 | Q6UVJ0 | |
| KDSTGAADPPQPHIV | 251 | Q9BQ95 | |
| SPEKPGAFLAQSPHV | 416 | P0C7X0 | |
| PVNSKAHTPPGNAEV | 61 | Q7L1W4 | |
| AHTPPGNAEVTTNIP | 66 | Q7L1W4 | |
| EGNQTVLHPPPSNTK | 31 | Q9H1H9 | |
| GSQAHVTPVAAVPGP | 301 | Q9UBD0 | |
| AIATPLPPTSAHGNV | 21 | P02790 | |
| PALPGSPANSHTQRD | 651 | Q8N2Y8 | |
| AVLQPSSPTPGHQAL | 121 | Q3SY00 | |
| TGPVRHAQPVPSAQD | 71 | A0A1B0GVQ0 | |
| TPHNADGAPVQPSQV | 341 | Q12872 | |
| SSTATHPPGPAVQLN | 661 | Q14684 | |
| HPPGPAVQLNKTPSS | 666 | Q14684 | |
| SEHNQASIVFPPPGA | 346 | Q8TEL6 | |
| VQEPHSAPAVVAATP | 121 | Q8N5C8 | |
| NSSPGHPGEVVLSPK | 891 | Q7Z7B0 | |
| APADQTQPPHGEASV | 76 | Q6T4R5 | |
| DFPLAHPVQSQPGLS | 51 | Q6ZSG1 | |
| VASNPVTPSLHSGPA | 91 | O95486 | |
| VNPSVNPSISPAHGV | 386 | Q15788 | |
| SPEKPGAFLAQSPHV | 416 | A8MX19 | |
| QQPVSAPVPIAAHAS | 46 | Q7Z3K3 | |
| SPEKPGAFLAQSPHV | 416 | P0C7W8 | |
| PDPPQAAAINVSTSH | 471 | O15197 | |
| SPQPAETHPTTLQGA | 231 | Q96D42 | |
| AKSPVPGVDPVVSHS | 1531 | O75376 | |
| SPEKPGAFLAQSPHV | 416 | D6RGX4 | |
| HENPSDPQTPLVFKG | 186 | Q5JRX3 | |
| PPAGQKTPDSGHVSQ | 516 | P47736 | |
| NASKGPHSPQVPSQV | 1071 | O43166 | |
| AHALGTLSAQQPPPA | 611 | Q8N196 | |
| PVVSGPAARATPQHT | 151 | P78324 | |
| QIHAPAPAPNDLATT | 281 | Q9NT68 | |
| SPGSENRAPSPHVVQ | 2911 | O75592 | |
| KPEGRPHTAVPTAVN | 151 | Q2NL68 | |
| PPHLKSPSAEATVAG | 686 | Q9P202 | |
| PVASQPPQHLSEAGR | 156 | Q9P2R6 | |
| VQPTAVPAQPAGASV | 696 | Q15714 | |
| QPVGQAPAAVSAVPT | 711 | Q15714 | |
| VTHAPRPAGNPQNAS | 156 | A1L4H1 | |
| LDPGHTAVAQAPPAV | 26 | Q9UHV2 | |
| APDGPQQKTSLPSAH | 776 | Q9NZP6 | |
| PAVHGLAVAPASVVP | 981 | Q8TAQ2 | |
| SPEKPGAFLAQSPHV | 416 | P0C7V4 | |
| HPKEQGSNTAPGPAL | 351 | Q5TFQ8 | |
| AGGAAPSHSQKPSVP | 526 | P0C7V6 | |
| AGTQAPPLHTATTNP | 1026 | P55197 | |
| PASHPVASNQSKEPA | 61 | Q96RK0 | |
| AQPSAHGALVPPATA | 61 | Q9P2W6 | |
| EQAPIPQDGLTVAPH | 331 | Q9C0B9 | |
| IASPNTAFIPIHNPG | 841 | Q9C0B9 | |
| LPASEGHLQPPAQTS | 246 | Q15735 | |
| AGTAKHPPPAASLEE | 56 | Q96N06 | |
| LQDAVGPPKVDPHSV | 146 | Q9UL52 | |
| GPPASQNVNSHVKEP | 131 | P10074 | |
| AVKDHNVGSPPKSPT | 406 | A0JNW5 | |
| AGRFPAQVPSAHQPS | 46 | Q8NHG8 | |
| AHPALAVTVPGPAEV | 511 | Q92738 | |
| PAPAVHLASPQAEST | 556 | Q9P243 | |
| SEPPSALVGAGHVAP | 281 | Q9H7S9 | |
| HQPVRGSAQPPASDL | 26 | Q6XCG6 | |
| LPQSTLPSPAEQHGA | 681 | Q2QGD7 | |
| GHTPPLAEAPKSVAS | 531 | Q6AWC2 | |
| PQAAAPAPAAHVAGN | 41 | P16989 | |
| ANNTVSHVPAPGSQP | 116 | Q96EK2 | |
| SHVPAPGSQPQALAE | 121 | Q96EK2 | |
| SIPPAAPGEAKSVHA | 721 | Q9HC29 | |
| APAEAPAQAQVHSPT | 201 | A0A1B0GUW6 | |
| RHPQDTPAQSGPLVA | 291 | Q8IWN7 | |
| AQHLSPAPGLAQPAA | 381 | Q9BW04 | |
| AHIPVPAQRATPGKA | 86 | Q9NR83 | |
| PANTPAEVPHSTGVA | 221 | Q9NP79 | |
| TSPLVTHQNPAGPVA | 506 | P43007 | |
| THQNPAGPVASAPEL | 511 | P43007 | |
| QHAASTPKASAGPQP | 936 | Q9Y490 | |
| PTPPAANEAHLQTAA | 26 | Q8TD17 | |
| HAVASATPVAVTAPP | 111 | Q9H0E3 | |
| TQAAPQAPPAGHQIV | 41 | P46937 | |
| AQPVHQLVKEPSTPA | 431 | P30530 | |
| VHKGSPEFPAQETPT | 571 | Q5JSZ5 | |
| AAAHGPVAPSSPEQV | 16 | P48067 | |
| AGFPVTVPAHPVAQQ | 501 | O75886 | |
| RQHAQPPKPSSDSSG | 711 | Q8TEA7 | |
| GLRSPASQEVQAHPP | 631 | O43151 | |
| PQDPQPGLTAHVVSA | 791 | Q9NNW5 | |
| ENGVNHTTTLTPKPP | 861 | Q9NQ66 | |
| PTPAPADISQKQVHR | 171 | P36402 | |
| RVSPAHSPPENGLDK | 261 | Q04726 | |
| HPPLQSAGPSEQVNS | 686 | P49750 | |
| VAHPVPSPKPASVQE | 251 | O15090 | |
| APHAGANVKPRNSTP | 231 | Q96GY0 | |
| PPSVVVTSHQAPGEK | 206 | P25311 | |
| IGESLSPPNPVNHQV | 521 | Q96NI8 | |
| HSGNPGPEQSIPKIS | 2221 | Q7Z7G8 | |
| HGAIKAGQEVTPPPA | 81 | Q8N831 | |
| TPGHLFPNVPAQEAS | 841 | Q5SXM2 | |
| HVQAPAATPLPKQEG | 946 | Q9H7P9 | |
| GENSVLHLPEAPPAA | 166 | Q96N03 | |
| VALPGGAQPVHSSPV | 426 | Q9BZR9 | |
| QPSVGHAVPAPKSQT | 216 | Q5T0J7 | |
| ETAHAADPQPRGPQA | 61 | Q8N6K4 | |
| VPNVHGALAPLAIPS | 301 | P26599 | |
| PQPAKVPTTVDQGHI | 1371 | Q702N8 | |
| GAAPQAPAAHQKPEA | 1506 | Q702N8 | |
| FSPGEHSNPSNKPTV | 481 | Q9H2Y7 | |
| APNAQTPSHLGATLP | 381 | P29353 | |
| APAPGGTHVVALVPA | 46 | Q562E7 | |
| IKQEPGEAPHVPATG | 591 | Q9ULM3 | |
| PGNVQPNSAPSVESH | 351 | Q9BYJ9 | |
| SIVHQKTPSPGPAPA | 281 | Q9H0D2 | |
| TQLPPQGRTTAHKDP | 131 | P40225 | |
| SPEKPGAFLAQSPHV | 416 | P0DV75 | |
| TAQNPAHEPSPGAPA | 511 | A6NN73 | |
| EGSPHDKPTAQPIVQ | 556 | A6NN73 | |
| ATPPPAPAARNKVAH | 486 | Q8WXH2 | |
| TGPQAAPSAFPHQEL | 111 | Q9H400 | |
| PVISQPIHDSKSPGA | 211 | Q00653 |